Gastro-oesophageal reflux disease

K11_REFLUX

gastroesophageal reflux disease: A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K21 Hospital discharge: ICD-9 — 5301A Cause of death: ICD-10 — K21 Cause of death: ICD-9 — 5301A 2 out of 7 registries used, show all original rules.	43899
4. Check minimum number of events None	43899
5. Include endpoints None	43899
6. Filter based on genotype QC (FinnGen only)	39461

Control definitions (FinnGen only)

Control exclude: K11_OESSTODUO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K20-K31
Name in latin: Morbus refluxualis gastro-oesophageus

NAME	K11_REFLUX
CONTROL_EXCLUDE	K11_OESSTODUO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K21
HD_ICD_9	5301A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K21
COD_ICD_9	5301A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Gastro-oesophageal reflux disease based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	244622	129853	113501
Only index persons	222545	121042	101503
Unadjusted period prevalence (%)
Whole population	3.45	3.72	3.17
Only index persons	4.19	4.45	3.87
Median age at first event (years)
Whole population	54.59	56.28	52.67
Only index persons	54.66	56.25	52.76

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	39461	23399	16062
Unadjusted period prevalence (%)	7.92	8.31	7.36
Median age at first event (years)	57.06	56.08	58.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
40903: Matched controls
344785

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

323.3

17921

117903

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

321.9

4870

23091

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

321.5

3487

14715

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

320.6

3657

15726

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

319.0

2896

11389

L15

ICPC

Knee symptom/complaint

1.6

317.7

9918

57477

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

317.7

15242

97214

K44.0

ICD-10 Finland

Diaphragmatic hernia with obstruction, without gangrene

13.5

317.5

329

207

K59.0

ICD-10 Finland

Constipation

2.4

317.4

2311

8254

C03CA01

ATC

furosemide; systemic

1.6

315.8

10454

61414

G04BD12

ATC

mirabegron; oral

1.9

311.3

4681

22135

H02AB07

ATC

prednisone; oral

1.8

311.2

5116

24887

J45

ICD-10 Finland

Asthma

1.9

310.7

4250

19476

R52.9

ICD-10 Finland

Pain, unspecified

2.1

307.7

4523

19203

N02BF01

ATC

gabapentin; oral

2.0

307.7

4372

19266

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

307.7

2878

10522

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

307.7

11575

60852

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

307.7

9482

47233

R01AD09

ATC

mometasone; nasal

1.7

307.7

18686

113800

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

307.7

28254

203454

K29.1

ICD-10 Finland

Other acute gastritis

19.0

307.7

579

261

A01

ICPC

Pain general/multiple sites

2.1

307.7

4142

17785

XJC00

NOMESCO Finland

Oesophageal manometry

51.8

307.7

402

R53

ICD-10 Finland

Malaise and fatigue

1.8

307.7

10558

54966

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

307.7

9562

48909

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

307.7

4532

18751

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

77.2

307.7

264

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

307.7

7854

40175

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

307.7

3896

16902

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.7

8839

48094

UJF30

NOMESCO Finland

Ileoscopy through colon

3.3

307.7

5783

16527

L03

ICPC

Low back symptom/complaint

1.8

307.7

12516

66468

G47.3

ICD-10 Finland

Sleep apnoea

1.9

307.7

10019

51295

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

307.7

13897

85737

Z01.2

ICD-10 Finland

Dental examination

1.6

307.7

18778

120612

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

307.7

5663

26061

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

307.7

7631

37067

M01AE02

ATC

naproxen; oral, rectal

1.6

307.7

22310

148060

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

307.7

9190

46327

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

75.7

307.7

365

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.5

307.7

2958

7555

J01MA02

ATC

ciprofloxacin; systemic

1.7

307.7

15586

91494

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

307.7

17665

108031

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

307.7

21679

147225

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

64.8

307.7

681

L17

ICPC

Foot/toe symptom/complaint

1.7

307.7

12418

71839

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

307.7

10660

57770

UJF32

NOMESCO Finland

Coloscopy

3.0

307.7

13753

50281

XF402

NOMESCO Finland

ECG with work load test

2.4

307.7

4509

16715

H02AB06

ATC

prednisolone; systemic

1.9

307.7

20370

118614

R01AD12

ATC

fluticasone furoate; nasal

1.6

307.7

12476

73870

L13

ICPC

Hip symptom/complaint

1.8

307.7

7783

40486

A02BC01

ATC

omeprazole; systemic

3.5

307.7

15561

51622

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

189.5

307.7

3212

155

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

102.6

307.7

254

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

51.0

307.7

502

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

307.7

10243

54837

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

154.1

307.7

23699

3054

R07.3

ICD-10 Finland

Other chest pain

2.5

307.7

4844

17856

K30

ICD-10 Finland

Functional dyspepsia

6.1

307.7

7334

12012

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

307.7

7746

38203

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

307.7

2388

8374

C05AA08

ATC

fluocortolone; rectal, topical

1.9

307.7

5363

25574

K22.2

ICD-10 Finland

Oesophageal obstruction

102.6

307.7

576

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.3

307.7

10341

31709

J01MA12

ATC

levofloxacin; systemic

1.9

307.7

7356

36003

A07AA02

ATC

nystatin; oral

2.5

307.7

2335

8250

J01FA10

ATC

azithromycin; systemic

1.6

307.7

22535

151098

A02BA04

ATC

nizatidine; systemic

3.1

307.7

3493

10138

G44.2

ICD-10 Finland

Tension-type headache

2.3

307.7

6364

25271

K29.4

ICD-10 Finland

Chronic atrophic gastritis

11.8

307.7

505

365

K29.7

ICD-10 Finland

Gastritis, unspecified

13.1

307.7

1677

1119

R05

ICPC

Cough

1.7

307.7

10112

56152

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

307.7

5864

24581

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

88.2

307.7

22366

4655

K29.3

ICD-10 Finland

Chronic superficial gastritis

49.6

307.7

1796

319

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.5

307.7

16771

106744

N02AX02

ATC

tramadol; systemic, rectal

2.0

307.7

18736

103509

M01AX17

ATC

nimesulide; oral

1.7

307.7

8958

48932

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

307.7

6359

31666

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

307.7

4036

15525

UKC02

NOMESCO Finland

Cystoscopy

1.9

307.7

6253

29639

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

307.7

3950

16162

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

307.7

13257

74957

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

307.7

28485

204792

R13

ICD-10 Finland

Dysphagia

4.8

307.7

4534

8775

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

6.3

307.7

1292

1786

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

307.7

18101

108853

K92.0

ICD-10 Finland

Haematemesis

6.1

307.7

1091

1538

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

307.7

20883

136547

N02BE01

ATC

paracetamol; systemic, rectal

2.5

307.7

37007

272818

C07AA05

ATC

propranolol; systemic

1.7

307.7

7756

41197

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

307.7

10622

60285

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

307.7

8492

46199

K29.6

ICD-10 Finland

Other gastritis

20.8

307.7

498

204

A02BA02

ATC

ranitidine; systemic

3.8

307.7

11156

31149

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

307.7

7558

36706

R01AD08

ATC

fluticasone; nasal

1.8

307.7

11863

63927

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

+∞

307.7

885

R12

ICD-10 Finland

Heartburn

4.6

307.7

6020

12529

A02BC03

ATC

lansoprazole; oral

4.0

307.7

17320

53887

N06AB04

ATC

citalopram; systemic

1.8

307.7

8221

41920

R06AE07

ATC

cetirizine; oral

1.6

307.7

17247

108975

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

23.0

307.7

628

234

J01FA06

ATC

roxithromycin; oral

1.6

307.7

15111

94118

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

59.8

307.7

289

XJC10

NOMESCO Finland

Oesophageal pH monitoring

64.3

307.7

668

K22.9

ICD-10 Finland

Disease of oesophagus, unspecified

21.0

307.7

317

128

N05CF01

ATC

zopiclone; oral

1.7

307.7

12512

71019

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

307.7

20916

115292

JBC00

NOMESCO Finland

Gastro-oesophageal antireflux operation

130.6

307.7

399

A02BX02

ATC

sucralfate; oral

3.8

307.7

1855

4309

M79.7

ICD-10 Finland

Fibromyalgia

3.0

307.7

1593

4567

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

307.7

4165

17094

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

20.4

307.7

28571

35172

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

307.7

3638

15024

A02BC02

ATC

pantoprazole; systemic

4.8

307.7

34378

179643

M02AA07

ATC

piroxicam; topical

1.6

307.7

13517

81362

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.1

307.7

4697

20004

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

161.0

307.7

341

K20

ICD-10 Finland

Oesophagitis

19.1

307.7

1153

523

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

6.5

307.7

619

817

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

9.0

307.7

630

600

J37.0

ICD-10 Finland

Chronic laryngitis

4.6

307.7

1976

3804

A02BDXX, ,

ATC

3.6

307.7

1451

3466

R03BA08

ATC

ciclesonide; inhalant

2.2

307.7

3813

15145

C01DA14

ATC

isosorbide mononitrate; oral

1.9

307.7

5247

25312

R4110, ,

SPAT

2.0

307.7

5783

26761

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.6

307.7

8887

33759

P01AB01

ATC

metronidazole; oral, rectal

1.8

307.7

16365

95011

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

103.2

307.7

207

A02BC04

ATC

rabeprazole; oral

5.6

307.7

6832

11879

SPAT1153

SPAT

Removal of sutures

1.6

307.7

11915

69871

N06AA09

ATC

amitriptyline; systemic

2.3

307.7

3906

14996

M70.6

ICD-10 Finland

Trochanteric bursitis

2.1

307.7

5733

24823

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.1

307.7

2905

8424

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.4

307.7

3082

11180

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

307.7

6060

25519

M03BX02

ATC

tizanidine; oral

1.7

307.7

25553

168856

R02

ICPC

Shortness of breath/dyspnoea

2.0

307.7

5739

25954

K92.1

ICD-10 Finland

Melaena

3.0

307.7

2031

5967

J01DB01

ATC

cefalexin; oral

1.9

307.7

33667

245115

R07.4

ICD-10 Finland

Chest pain, unspecified

2.5

307.7

13925

59296

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

307.7

11845

69978

A03CA02

ATC

clidinium and psycholeptics; oral

2.8

307.7

2407

7455

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

307.7

3993

16950

M01AC06

ATC

meloxicam; systemic, rectal

1.6

307.7

13817

84222

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

307.7

5773

28495

M01AH02

ATC

rofecoxib; oral

1.9

307.7

4753

22206

L01

ICPC

Neck symptom/complaint

1.9

307.7

6968

33049

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.5

307.7

2577

9182

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

307.7

5338

23813

D03

ICPC

Heartburn

5.0

307.7

2492

4415

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

307.7

8666

37930

R00.2

ICD-10 Finland

Palpitations

2.2

307.7

3372

13576

M01AB05

ATC

diclofenac; systemic, rectal

1.6

307.7

26092

182226

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

307.7

5136

23437

M01AH01

ATC

celecoxib; oral

1.9

307.7

7172

35475

R42

ICD-10 Finland

Dizziness and giddiness

2.0

307.7

10021

48782

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

43.1

307.7

249

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

307.7

8515

46598

M01AH05

ATC

etoricoxib; oral

1.7

307.7

25575

171285

R01AD58

ATC

fluticasone, combinations; nasal

1.6

307.7

9967

56352

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

307.7

23217

160505

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

307.7

3239

12937

N06AX21

ATC

duloxetine; oral

2.3

307.7

5437

21585

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.2

307.7

1490

4071

K22.7

ICD-10 Finland

Barrett oesophagus

64.9

307.7

1255

168

M79.1

ICD-10 Finland

Myalgia

2.0

307.7

6425

29315

N05BA04

ATC

oxazepam; oral

1.8

307.7

10569

56397

R05

ICD-10 Finland

Cough

2.1

307.7

9835

45796

R03BA05

ATC

fluticasone; inhalant

1.9

307.7

7672

36562

K22.1

ICD-10 Finland

Ulcer of oesophagus

215.7

307.7

1456

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

307.7

16633

101394

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

145.9

307.7

258

R07.0

ICD-10 Finland

Pain in throat

2.3

307.7

3085

12008

M25.5

ICD-10 Finland

Pain in joint

1.8

307.7

13965

78339

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

307.7

13154

53674

AA1AD

NOMESCO Finland

CT of head and brain

1.7

307.7

11428

62808

UJC12

NOMESCO Finland

Flexible oesophagoscopy

9.4

307.7

444

404

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

307.7

19593

130404

A06AD11

ATC

lactulose; oral

1.9

307.7

5310

25206

J01CA04

ATC

amoxicillin; systemic

1.7

307.7

32524

240164

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

33.2

307.7

1319

346

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

167.7

307.7

198

J01FA09

ATC

clarithromycin; systemic

1.7

307.7

12384

70670

R06.0

ICD-10 Finland

Dyspnoea

2.3

307.7

12684

57304

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

19077

110580

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

101.4

307.7

263

R11

ICD-10 Finland

Nausea and vomiting

2.7

307.7

4017

13540

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

307.7

3292

11626

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

4.3

307.7

1825

3671

R03AC02

ATC

salbutamol; inhalant

2.1

307.7

24116

141707

R03BB04

ATC

tiotropium bromide; inhalant

2.1

307.7

3898

16468

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.2

307.7

3513

13910

M01AB55

ATC

diclofenac, combinations; oral

2.4

307.7

2544

9326

A03FA02

ATC

cisapride; oral, rectal

4.3

307.7

4420

9351

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

8.1

307.7

5877

6960

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.0

307.7

4520

20083

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

307.7

10710

47937

N06AX11

ATC

mirtazapine; oral

1.8

307.7

14411

79229

R96

ICPC

Asthma

2.1

307.7

4154

17728

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

307.7

10698

49273

S18

ICPC

Laceration/cut

1.6

307.7

18634

119691

N03AX16

ATC

[U] pregabalin

2.2

307.7

10426

46450

R51.80

ICD-10 Finland

Headache

2.3

307.7

7152

29522

SPAT1263

SPAT

Sampling

1.7

307.7

16672

99205

K29.8

ICD-10 Finland

Duodenitis

87.1

307.7

399

A06AC51

ATC

ispaghula, combinations; oral

2.8

307.7

2126

6621

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.8

307.7

19047

80946

N03AX12

ATC

[U] gabapentin; oral

2.2

307.7

7038

30157

A11

ICPC

Chest pain NOS

2.3

307.7

3658

14417

R03DC03

ATC

montelukast; oral

2.0

307.7

7263

32946

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

307.7

10002

55697

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.6

307.7

2316

7877

M54.5

ICD-10 Finland

Low back pain

1.9

307.7

15970

87574

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

307.7

5560

24328

D02

ICPC

Abdominal pain epigastric

3.1

307.7

3130

8981

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

307.7

5650

23743

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

33.2

307.7

448

115

R03BA02

ATC

budesonide; inhalant

1.8

307.7

7110

36244

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

122.9

307.7

490

A02BC05

ATC

esomeprazole; systemic

5.7

307.7

26770

85945

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

307.7

17343

103095

WX002

NOMESCO Finland

Sedation and analgesia

1.9

307.7

7525

37000

C07AB07

ATC

bisoprolol; oral

1.7

307.7

19163

116803

J02AC01

ATC

fluconazole; systemic

1.7

307.7

16072

93144

N06AX16

ATC

venlafaxine; oral

1.9

307.7

5740

27340

UJD02

NOMESCO Finland

Gastroscopy

10.0

307.7

3656

3354

L08

ICPC

Shoulder symptom/complaint

1.7

307.7

9442

51458

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

307.7

4942

23472

D01

ICPC

Abdominal pain/cramps general

2.2

307.7

5422

22158

K44

ICD-10 Finland

Diaphragmatic hernia

8.4

307.7

596

608

A02BA03

ATC

famotidine; systemic

3.6

307.7

1646

4019

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

13.7

307.7

8633

6626

H02AB04

ATC

methylprednisolone; systemic

2.0

307.7

5858

27093

J01AA02

ATC

doxycycline; systemic

1.9

307.7

31760

222579

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

307.7

7796

39479

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

307.7

2787

10458

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

307.7

8145

44609

D06

ICPC

Abdominal pain localized other

2.1

307.7

3751

15666

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

2.6

307.7

2644

8860

6241

FHL

Fund application (Nissen)

151.3

307.7

444

UJF92

NOMESCO Finland

Capsular endoscopy

4.3

307.7

982

1978

SFA10

NOMESCO Finland

One-surface restoration

1.5

306.0

21365

146619

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.3

305.0

2437

9072

C10AA05

ATC

atorvastatin; oral

1.5

302.8

15833

102494

R03AK08

ATC

formoterol and beclometasone; inhalant

2.6

301.5

1975

6706

K22.8

ICD-10 Finland

Other specified diseases of oesophagus

33.6

300.1

218

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

300.0

11238

67754

XG410

NOMESCO Finland

Flow-volume spirometry

2.8

298.9

1614

4963

J01DA01

ATC

[U] cefalexin

1.5

298.9

23418

164053

C08CA01

ATC

amlodipine; oral

1.5

297.7

14223

90294

M48.0

ICD-10 Finland

Spinal stenosis

1.9

294.4

4594

21958

N17

ICPC

Vertigo/dizziness

1.8

293.9

4959

24287

M54.2

ICD-10 Finland

Cervicalgia

2.1

292.4

3292

14066

J01FF01

ATC

clindamycin; systemic

1.6

292.1

10197

60443

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

291.9

11730

71726

A01AB09

ATC

miconazole; local oral

2.1

288.9

3217

13687

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

288.3

8117

45714

A04

ICPC

Weakness/tiredness general

1.7

284.6

6044

31620

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

283.9

4868

23940

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.4

283.5

2107

7587

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

283.4

8806

50753

C10AC01

ATC

colestyramine; oral

3.2

282.9

1206

3237

SPAT1097

SPAT

Recording of ECG

1.8

282.5

5288

26690

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

281.7

1625

5173

R06AX27

ATC

desloratadine; oral

1.5

281.7

10934

66256

M01AX05

ATC

glucosamine; oral

1.7

281.5

6711

36210

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

279.1

4942

24532

C10AA01

ATC

simvastatin; oral

1.5

278.6

14571

93869

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

278.1

3713

16842

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.9

277.8

1448

4366

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

276.0

3028

12803

R52.2

ICD-10 Finland

Other chronic pain

2.7

274.3

1574

4996

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

274.2

14142

90775

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

272.4

11179

68456

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.8

271.1

1429

4335

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

270.6

2865

11950

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

268.9

2392

9309

R35

ICD-10 Finland

Polyuria

2.1

268.1

2725

11187

E0000UV, ,

ATC

1.5

265.1

15791

104040

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

264.5

3660

16790

N05AH04

ATC

quetiapine; oral

1.7

262.2

6534

35590

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

259.6

25774

186333

SPAT1310

SPAT

Counselling related to known health issue

1.5

259.6

11507

71458

J01EA01

ATC

trimethoprim; systemic

1.5

258.7

9250

54871

N05BA12

ATC

alprazolam; oral

1.9

258.4

3686

17073

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

258.1

5889

31338

N06AB10

ATC

escitalopram; oral

1.6

257.3

7616

43258

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.6

257.3

1562

5101

SPAT1058

SPAT

PEF monitoring instruction

2.0

256.8

3002

12982

SPAT1301

SPAT

No procedures

1.5

256.7

11278

69874

XQ800

NOMESCO Finland

Prick test

2.1

256.5

2801

11812

R21

ICPC

Throat symptom/complaint

1.6

255.8

7805

44640

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

2.5

254.9

1669

5658

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

5.1

254.8

578

972

N01

ICPC

Headache

1.8

254.3

4131

19938

L02

ICPC

Back symptom/complaint

1.8

253.8

4011

19194

R49.01

ICD-10 Finland

Functional dysphonia

2.9

253.4

1267

3731

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

252.7

2056

7699

H25.8

ICD-10 Finland

Other senile cataract

1.9

252.5

3822

18040

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.1

252.2

2823

12012

N30.0

ICD-10 Finland

Acute cystitis

1.6

251.2

6397

34998

N05CF02

ATC

zolpidem; oral

1.6

251.0

6472

35518

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

250.8

6326

34523

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

250.7

5853

31312

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

248.6

2198

8525

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

248.2

13261

85279

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

246.7

14307

93419

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.8

245.9

3960

19052

WX320

NOMESCO Finland

Spinalanesthesy

1.5

244.9

9041

53904

D11

ICPC

Diarrhoea

1.8

244.5

4535

22759

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

244.1

4628

23373

N05BA01

ATC

diazepam; systemic, rectal

1.8

243.9

4609

23254

R74

ICPC

Upper respiratory infection acute

1.5

242.0

12272

78036

SPAT1312

SPAT

General health counselling

1.5

241.9

11357

71132

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

237.3

2838

12360

N04BC05

ATC

pramipexole; oral

2.0

236.7

2812

12218

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

234.9

2982

13261

N02BF02

ATC

pregabalin; oral

2.0

234.4

2676

11459

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

233.8

5232

27637

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

233.4

5291

28041

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.3

233.4

1993

7614

J20

ICD-10 Finland

Acute bronchitis

1.8

233.1

4053

19940

C07AB02

ATC

metoprolol; systemic

1.6

233.1

6737

37944

R03BA01

ATC

beclometasone; inhalant

1.7

232.9

5095

26747

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

232.9

9502

57763

U02

ICPC

Urinary frequency/urgency

1.7

232.5

5489

29399

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

231.7

3786

18279

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

231.0

4790

24780

K02.1

ICD-10 Finland

Caries of dentine

1.4

230.7

22477

160221

N06AB03

ATC

fluoxetine; oral

1.7

230.0

4420

22384

J01CA08

ATC

pivmecillinam; oral

1.4

229.5

14335

94540

D07AC01

ATC

betamethasone; topical

1.4

228.1

13572

88692

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.3

227.7

1867

7009

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

227.4

7164

41138

K22.5

ICD-10 Finland

Diverticulum of oesophagus, acquired

84.6

227.3

140

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.0

227.1

2638

11363

SFA20

NOMESCO Finland

Two-surface restoration

1.4

227.1

22360

159473

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

226.8

4007

19799

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

226.2

4354

22051

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

226.1

10680

66794

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

226.0

5275

28153

M02AA10

ATC

ketoprofen; topical

1.6

225.3

5816

31843

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.8

225.0

4093

20394

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

223.6

14347

94951

A07EA06

ATC

budesonide; oral, local oral

2.5

222.8

1481

5053

D84

ICPC

Oesophagus disease

11.9

222.7

248

177

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

222.5

9005

54564

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

221.9

10443

65218

L28

ICPC

Limited function/disability (L)

1.6

221.3

6749

38441

DFF00

NOMESCO Finland

Pure tone audiometry

1.8

221.1

3834

18832

K22.0

ICD-10 Finland

Achalasia of cardia

257.2

221.0

241

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

221.0

2793

12393

N05CD07

ATC

temazepam; oral

1.8

220.9

3910

19320

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

220.3

3022

13787

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

219.9

2474

10531

G04BD08

ATC

solifenacin; oral

2.1

219.8

2392

10056

R60.0

ICD-10 Finland

Localized oedema

1.7

219.8

4648

24152

R03AC03

ATC

terbutaline; inhalant

1.7

218.5

4971

26336

WW200, ,

SPAT

1.5

217.1

11227

71333

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

215.6

3701

18116

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

214.8

4839

25560

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

212.4

3327

15833

SPAT1254

SPAT

Administration of medicine

1.7

212.1

5100

27392

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

211.9

9029

55200

JBB01

NOMESCO Finland

Laparoscopic repair of paraoesophageal hernia

9.2

211.7

278

255

R49.08

ICD-10 Finland

Other specified dysphonia

3.1

210.4

952

2645

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.9

210.1

1073

3195

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

209.8

15755

106805

C10AA07

ATC

rosuvastatin; oral

1.4

209.3

12530

81658

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

208.1

2375

10156

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

208.0

2524

11033

SPAT1260

SPAT

Consultation of another employee

1.6

207.8

6240

35357

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

207.8

2610

11548

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

207.3

3171

14973

EB1VA, ,

NOMESCO Finland

1.5

206.0

6936

40321

UJD10, ,

SPAT

2.8

205.7

1073

3232

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

205.4

4425

23080

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.9

204.8

2735

12354

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

204.8

9205

56811

C09CA06

ATC

candesartan; oral

1.5

204.4

9027

55515

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

202.9

10703

68078

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.6

202.8

1296

4336

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

202.6

2701

12192

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.0

201.9

2404

10435

K07.60

ICD-10 Finland

Snapping jaw

2.2

201.8

1947

7810

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

201.4

8427

51249

SFA30

NOMESCO Finland

Three-surface restoration

1.4

200.1

15893

108478

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

200.1

3400

16575

L12

ICPC

Hand/finger symptom/complaint

1.6

199.7

6408

36828

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

198.1

7203

42534

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

197.6

13881

92773

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

197.0

3629

18111

SPAT1104

SPAT

Monitoring of emergency patient

2.0

196.9

2304

9936

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

4.0

196.9

591

1250

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

196.4

7019

41283

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

195.7

3873

19723

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

195.4

2247

9630

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

195.1

7791

46893

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

195.0

5109

27989

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

194.9

9936

62712

R06.5

ICD-10 Finland

Mouth breathing

1.8

194.6

3357

16432

N03AE01

ATC

clonazepam; systemic

2.1

194.5

2024

8358

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

194.4

3263

15842

L04

ICPC

Chest symptom/complaint

2.0

194.0

2424

10697

L16

ICPC

Ankle symptom/complaint

1.7

193.6

4395

23217

G04CA02

ATC

tamsulosin; oral

1.5

192.8

7808

47112

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

192.5

2947

13906

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.8

192.4

1039

3188

D82

ICPC

Teeth/gum disease

1.4

191.8

13776

92291

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

190.9

2179

9311

K58

ICD-10 Finland

Irritable bowel syndrome

2.7

190.1

1072

3366

N39.3

ICD-10 Finland

Stress incontinence

1.9

190.0

2655

12166

K08.80

ICD-10 Finland

Toothache NOS

1.8

189.5

3409

16886

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

189.2

4145

21685

M54

ICD-10 Finland

Dorsalgia

1.6

188.9

4632

24946

R03AC12

ATC

salmeterol; inhalant

2.3

188.4

1576

5960

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.2

188.1

1629

6250

JBB97

NOMESCO Finland

Laparoscopic repair of other diaphragmatic hernia

20.5

187.8

160

B01AB05

ATC

enoxaparin; parenteral

1.4

187.7

11129

72091

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

187.3

11072

71679

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.7

186.9

631

1453

H03AA01

ATC

levothyroxine sodium; systemic

1.5

186.4

8116

49635

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

186.4

1642

6345

R06AX22

ATC

ebastine; oral

1.5

186.3

6163

35602

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

186.0

6141

35459

N06AB06

ATC

sertraline; oral

1.7

185.9

4000

20821

N02AA05

ATC

oxycodone; systemic

1.5

185.9

6197

35859

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

185.7

6039

34753

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

185.4

4584

24732

J01MA01

ATC

ofloxacin; systemic

1.9

185.4

2814

13238

R51

ICD-10 Finland

Headache

2.0

185.2

2112

9020

S06.0

ICD-10 Finland

Concussion

1.7

183.9

3879

20082

N81.6

ICD-10 Finland

Rectocele

2.0

183.3

2319

10273

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.7

182.3

4223

22403

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

182.0

3874

20101

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

181.8

5108

28417

XKD00

NOMESCO Finland

Uroflowmetry

1.6

181.5

5239

29331

R06.2

ICD-10 Finland

Wheezing

2.2

181.1

1703

6757

SPAT1325

SPAT

Vaccination

1.4

181.1

11332

73998

A01AB04

ATC

amphotericin B; local oral

2.2

181.0

1591

6141

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.9

180.8

881

2554

N41.1

ICD-10 Finland

Chronic prostatitis

2.8

180.8

953

2886

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.6

179.4

1128

3742

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

179.1

11394

74581

5308A

ICD-9 Finland

Diseases of oesophagus, Other specified disorders of oesophagus[HERNIA HIATUS OESOPHAGI (""""SLIDING HERNIA"""")]

+∞

178.5

183

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

178.0

1962

8272

G04CA01

ATC

alfuzosin; oral

1.7

178.0

4154

22071

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

3.1

177.5

793

2186

SPAT1211

SPAT

Application of soft bandage

1.8

177.0

3022

14729

I20.09

ICD-10 Finland

Unstable angina

2.1

176.2

1869

7769

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.3

175.9

1480

5608

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

174.6

9037

56995

L05

ICPC

Flank/axilla symptom/complaint

1.9

174.2

2358

10682

R55

ICD-10 Finland

Syncope and collapse

1.7

174.0

3840

20102

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

172.9

7034

42362

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

172.5

1479

5648

R09

ICPC

Sinus symptom/complaint

1.8

172.2

2949

14382

P06

ICPC

Sleep disturbance

1.6

171.3

4709

26035

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

171.2

3481

17823

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.2

171.1

1545

6028

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.3

170.7

684

1764

J01MA06

ATC

norfloxacin; oral

1.6

170.1

4379

23827

C10AX09

ATC

ezetimibe; oral

1.5

169.7

6014

35190

G43.9

ICD-10 Finland

Migraine, unspecified

2.0

169.3

2146

9506

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

169.2

2923

14290

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

169.0

2079

9115

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.5

168.8

1105

3738

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

168.7

1756

7244

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

168.6

3477

17870

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

168.4

2455

11390

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

167.8

4605

25440

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

5.8

167.6

330

486

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

167.5

3156

15818

S29

ICPC

Skin symptom/complaint other

1.5

166.4

7379

45154

R04.2

ICD-10 Finland

Haemoptysis

2.4

166.0

1207

4289

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

165.9

3465

17864

R51.81

ICD-10 Finland

Facial pain NOS

2.7

165.5

942

2971

X58

ICD-10 Finland

Exposure to other specified factors

1.5

164.4

5359

30779

U07

ICPC

Urine symptom/complaint other

1.7

163.2

3047

15228

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

162.9

2299

10553

R03AC13

ATC

formoterol; inhalant

2.1

162.7

1745

7279

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

162.5

2061

9129

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

162.2

3376

17385

SPAT1240

SPAT

Therapeutic discussion

1.7

161.9

3478

18061

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

161.3

4551

25291

H01

ICPC

Ear pain/earache

1.6

161.2

4198

22887

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

161.0

8706

55212

UJC02

NOMESCO Finland

Rigid oesophagoscopy

5.3

161.0

345

551

K29.2

ICD-10 Finland

Alcoholic gastritis

52.7

160.8

106

R07.2

ICD-10 Finland

Precordial pain

2.9

160.7

822

2448

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

160.7

2410

11278

R63.4

ICD-10 Finland

Abnormal weight loss

2.2

160.1

1399

5383

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

159.7

2637

12711

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

159.4

4787

26981

C09CA01

ATC

losartan; oral

1.4

159.0

8977

57344

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

158.7

2974

14873

A07EC02

ATC

mesalazine; oral, rectal

2.0

157.8

1863

8047

K80

ICPC

Cardiac arrhythmia NOS

1.7

156.8

3039

15341

XF404

NOMESCO Finland

Ambulatory ECG

1.7

156.5

2881

14333

R50.9

ICD-10 Finland

Fever, unspecified

1.5

156.3

5288

30586

H92.0

ICD-10 Finland

Otalgia

1.9

155.8

2329

10885

J34.2

ICD-10 Finland

Deviated nasal septum

2.0

154.3

1919

8439

FN1AD

NOMESCO Finland

CT of coronary arteries

2.9

154.2

776

2290

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.4

154.0

1133

4046

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.0

153.2

1793

7719

WX290

NOMESCO Finland

Other blockage of nerve

1.3

153.0

17212

122199

L86

ICPC

Back syndrome with radiating pain

1.9

152.3

2244

10439

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.4

152.1

1088

3836

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

152.1

2269

10596

J45.8

ICD-10 Finland

Mixed asthma

2.4

151.9

1102

3910

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.5

151.8

1029

3538

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

151.5

1101

3910

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

151.2

5589

32915

M54.3

ICD-10 Finland

Sciatica

1.9

150.8

2118

9701

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

150.7

6112

36673

R32

ICD-10 Finland

Unspecified urinary incontinence

2.5

150.6

1017

3491

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

150.5

5034

29028

ZXA10

NOMESCO Finland

Bilateral

1.5

150.4

6146

36929

B01AC04

ATC

clopidogrel; oral

1.5

150.3

5226

30385

J46

ICD-10 Finland

Status asthmaticus

2.4

150.2

1057

3698

J01DA09

ATC

[U] cefadroxil

1.4

150.0

9129

58970

SPAT1216

SPAT

Assessment of functional ability

1.5

149.9

5051

29168

UDC00

NOMESCO Finland

Ear microscopy

1.8

149.4

2605

12753

M15

ICD-10 Finland

Polyarthrosis

2.0

149.2

1793

7790

DAX08

NOMESCO Finland

Fitting of hearing aid

1.9

148.6

1984

8935

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

148.5

3419

18057

N06AX26

ATC

vortioxetine; oral

1.8

148.5

2677

13231

R15

ICD-10 Finland

Faecal incontinence

2.5

148.4

1025

3555

JN4AD

NOMESCO Finland

Body CT examination

1.6

148.4

3962

21705

J05AB01

ATC

aciclovir; systemic

1.4

148.2

7626

47836

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026493) Urate [Moles/volume] in Serum or Plasma

12866

79064

1.54

319.33

3.0

2.6

340.68

340.56

umol/l

0.05

11229

70373

(3028026) IgM [Mass/volume] in Serum or Plasma

3816

16715

2.02

317.89

1.9

2.0

1.32

1.29

g/l

0.33

3481

15423

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

22469

130586

2.00

307.65

7.4

6.4

1.21

mmol/l

10.61

20508

121318

(3015736) pH of Urine

19688

126351

1.60

307.65

4.0

3.3

6.19

6.20

0.58

11231

70339

(3022948) Iron [Moles/volume] in Serum or Plasma

9818

48825

1.91

307.65

2.9

2.5

13.03

13.82

umol/l

1.21

9104

45582

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5549

26772

1.86

307.65

2.4

2.2

0.22

0.21

g/l

4.37

5179

24997

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

22118

133843

1.86

307.65

2.9

2.4

77.95

747.28

nmol/l

0.50

19811

122361

(3018010) Neutrophils/Leukocytes in Blood

23367

139387

1.96

307.65

7.1

6.3

56.88

57.25

5.02

22157

133635

(3019198) Lymphocytes [#/volume] in Blood

25203

154169

1.98

307.65

7.2

6.3

1.93

1.92

e9/l

0.26

22664

135229

(3013650) Neutrophils [#/volume] in Blood by Automated count

26642

169084

1.94

307.65

9.8

9.7

4.08

4.12

e9/l

2.01

23696

145834

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

33589

217852

2.68

307.65

5.8

4.1

11.69

11.73

mm/h

0.25

31534

204500

(3021960) Folate [Moles/volume] in Serum or Plasma

15137

80127

1.94

307.65

1.8

1.6

20.53

20.04

nmol/l

2.71

12644

68563

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

9653

51059

1.78

307.65

1.4

1.3

9.30

10.93

u/ml

1.36

3337

20730

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

36750

281513

1.99

307.65

20.0

14.5

80.13

81.98

ml/min/173m2

56.44

34481

259465

(3019225) pH of Specimen

6601

25390

2.42

307.65

4.3

4.1

7.37

7.36

4.39

4597

18290

(3019309) Folate [Moles/volume] in Red Blood Cells

9606

45086

2.04

307.65

1.8

1.7

1099.53

1175.40

nmol/l

12.75

7208

34309

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4436

18498

2.15

307.65

4.0

3.7

5.10

5.14

kpa

2.91

4229

17637

(3013139) Helicobacter pylori Ag [Presence] in Stool

5201

17172

2.78

307.65

1.3

1.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

4972

21632

2.07

307.65

1.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

24674

146551

2.06

307.65

8.3

6.9

1.22

1.21

mmol/l

5.97

21186

126512

(3001604) Monocytes [#/volume] in Blood

24808

150624

1.99

307.65

7.1

6.2

0.58

e9/l

0.66

21868

129059

(3013512) EKG study

17802

97561

1.95

307.65

4.5

3.4

0.66

0.75

0.50

245

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

22438

127027

2.08

307.65

2.4

2.0

99.31

96.42

pmol/l

13.95

12056

67554

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

466

393

10.10

307.65

1.0

—

(36660697) Celiac disease serology panel - Serum

5128

22603

2.04

307.65

1.2

—

(40768797) Stomach Pathology biopsy report

16666

26638

8.21

307.65

1.4

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7127

37798

1.71

307.65

6.7

5.9

1.04

mmol/l

0.79

6631

35189

(3023368) Bacteria identified in Blood by Culture

13079

79999

1.56

307.65

4.8

4.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

19241

88899

2.56

307.65

3.2

2.5

59.31

68.09

u/l

0.67

17874

82310

(42870588) Differential panel, method unspecified - Blood

18430

98721

2.04

307.65

6.9

6.3

5.32

5.51

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

14714

72624

2.11

307.65

2.8

2.2

2.86

2.75

mg/l

6.26

12760

62618

(3002030) Lymphocytes/Leukocytes in Blood

23628

142246

1.95

307.65

7.3

6.4

28.08

27.90

1.63

22428

135167

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

15736

83286

1.96

307.65

3.3

3.1

1216.28

1329.61

ng/l

2.18

13143

71509

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

36904

280837

2.10

307.65

6.2

4.9

5.97

5.91

mmol/l

14.68

33842

260378

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

11957

64056

1.81

307.65

1.9

1.7

1.06

1.23

mg/l

7.07

9057

49937

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

36479

275962

2.06

307.65

7.7

6.0

39.50

39.08

mmol/mol

16.16

33972

259604

(3015377) Calcium [Moles/volume] in Serum or Plasma

16555

101715

1.62

307.65

3.2

3.6

2.35

2.36

mmol/l

8.57

14679

93291

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

21179

137408

1.62

307.65

3.1

2.7

—

estimate

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

13594

65352

2.13

307.65

1.4

1.3

1.55

1.65

u/ml

0.41

3325

18470

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9765

55096

1.65

307.65

4.8

3.6

332.22

526.09

ng/l

3.67

7242

42310

(3019069) Monocytes/Leukocytes in Blood

23384

138485

1.99

307.65

7.4

6.5

8.79

8.82

0.99

21878

130361

(3017732) Neutrophils [#/volume] in Blood

7128

37017

1.75

307.65

3.2

3.1

4.31

4.53

e9/l

1.61

5762

32447

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

10505

59377

1.66

307.65

1.8

1.7

80122161.60

28205302.36

pmol/l

7.48

8708

49534

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8906

48348

1.71

307.65

3.6

3.4

0.81

0.82

mmol/l

4.41

8314

45531

(3009261) Glucose [Presence] in Urine by Test strip

24142

160341

1.66

307.65

4.7

3.7

0.24

0.36

estimate

0.20

4565

31814

(3035350) Ketones [Presence] in Urine by Test strip

23980

159200

1.65

307.65

4.7

3.7

4.57

3.70

estimate

0.32

4832

33685

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

26962

151624

2.46

307.65

6.8

6.4

10.77

11.58

umol/l

23.25

25734

144392

(3032080) INR in Blood by Coagulation assay

22811

133048

2.01

307.65

14.6

14.1

1.21

1.25

inr

22.08

19116

110719

(3001122) Ferritin [Mass/volume] in Serum or Plasma

22932

139409

1.88

307.65

3.9

2.9

117.66

127.69

ug/l

5.56

21282

130698

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9181

45411

1.91

307.65

2.9

2.5

2.39

2.32

g/l

21.50

8438

41974

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

32822

229378

2.04

307.65

5.3

4.3

14.83

14.72

pmol/l

14.27

30177

212052

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2550

7455

3.01

307.65

1.5

1.4

286.57

270.23

ug/g

3.03

1411

4322

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

29468

201808

1.83

307.65

4.3

3.1

50.88

46.67

u/l

10.22

27685

190532

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

19837

108239

2.06

307.65

4.7

3.4

43.64

70.84

ng/l

2.32

13777

73157

(3007164) IgA [Mass/volume] in Serum or Plasma

11797

56633

2.06

307.65

1.6

1.5

2.38

2.37

g/l

0.15

7048

35753

(3024561) Albumin [Mass/volume] in Serum or Plasma

22181

130719

1.94

307.65

5.6

4.8

35.97

35.82

g/l

3.59

20735

122546

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

36804

271926

2.41

307.65

6.8

5.2

1.84

1.90

mu/l

16.31

34160

253335

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16492

99180

1.67

307.65

3.7

3.2

33.47

33.24

u/l

0.09

15476

93763

(3013826) Glucose [Moles/volume] in Serum or Plasma

27380

172247

2.03

307.65

5.9

4.8

6.61

6.69

mmol/l

8.49

26166

163139

(3022096) Basophils/Leukocytes in Blood

23337

138138

1.99

307.65

7.4

6.5

0.69

0.68

2.87

21798

129809

(3023103) Potassium [Moles/volume] in Serum or Plasma

38774

298076

2.85

307.65

25.2

17.3

3.97

mmol/l

0.86

38162

291939

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

16458

105930

1.52

307.65

4.0

3.3

1.58

2.02

e6/l

0.41

(3037467) Urinalysis macro (dipstick) panel - Urine

30777

200346

2.19

307.65

5.9

4.3

231.64

4.13

0.49

285

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10313

55488

1.76

307.65

1.4

1.3

28.25

36.15

iu/ml

3.96

3061

17001

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4609

19722

2.09

307.65

1.7

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6755

32517

1.90

307.65

2.8

2.6

7.35

8.67

umol/l

5.78

5859

28392

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5766

26793

1.95

307.65

2.2

2.4

365.43

380.30

nmol/l

5.56

5286

25034

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

12562

70733

1.72

307.65

2.6

2.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3505

8771

3.59

307.65

1.6

13.25

16.74

u/ml

2.06

612

2369

(3019550) Sodium [Moles/volume] in Serum or Plasma

38745

297432

2.86

307.65

24.9

17.1

139.64

139.72

mmol/l

8.70

38185

291763

(3005322) IgE [Units/volume] in Serum or Plasma

4443

19011

2.09

307.65

1.4

1.3

174.64

249.05

u/ml

5.56

4167

17748

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

34505

225309

2.86

307.65

10.0

7.8

78.90

78.84

u/l

0.07

33010

214092

(3027945) Reticulocytes/Erythrocytes in Blood

6418

31667

1.84

307.65

2.6

1.76

1.75

0.51

5565

28404

(3006504) Eosinophils/Leukocytes in Blood

23366

138051

2.00

307.65

7.3

6.4

2.89

2.84

2.67

21846

129868

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3447

14362

2.12

307.65

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

8811

47505

1.72

307.65

2.2

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

5090

24191

1.88

307.65

2.6

68.91

69.13

e9/l

0.16

3927

17458

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2654

9739

2.39

307.65

4.3

3.9

24.76

24.83

mmol/l

0.60

2461

8971

(3037522) Nuclear Ab [Titer] in Serum

8429

40945

1.93

307.65

1.4

565.24

504.33

titre

1.99

1939

8404

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7765

33007

2.21

307.65

5.4

4.8

32.54

32.15

2.27

5357

22368

(3013115) Eosinophils [#/volume] in Blood

25606

155486

2.04

307.65

7.3

6.4

0.19

e9/l

0.49

22753

135445

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3785

15695

2.14

307.65

3.9

3.6

1.43

1.79

mmol/l

7.57

2837

11521

(3048689) Calprotectin [Mass/mass] in Stool

9025

35641

2.46

307.65

2.6

2.4

128.17

129.82

ug/g

0.17

7141

28273

(3006315) Basophils [#/volume] in Blood

24890

151006

1.99

307.65

7.1

6.2

0.04

e9/l

0.96

21916

129355

(3005719) IgG [Mass/volume] in Serum or Plasma

4830

21721

1.99

307.65

2.9

10.34

10.59

g/l

3.38

4433

20119

(3022145) Colonoscopy Study observation

7877

31746

2.35

307.65

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8510

41677

1.91

307.65

2.9

2.5

22.13

23.11

8.83

7852

38720

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

16234

89679

1.87

307.65

2.5

2.1

180.56

212.16

u/l

2.97

15414

84759

(3031040) Bacteria [#/volume] in Urine by Automated count

29330

190706

2.05

307.65

6.0

4.4

1254.15

1747.57

e6/l

0.69

303

2822

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

38505

291660

2.92

307.65

22.1

14.6

20.82

24.67

mg/l

109.61

33668

237969

(3009343) pH of Capillary blood

4314

17969

2.14

307.65

4.0

3.7

7.42

0.31

3599

14925

(3021601) Nitrite [Presence] in Urine by Test strip

23682

157392

1.64

307.65

4.6

3.7

0.00

estimate

0.59

4746

32936

(3045414) Leukocytes [Presence] in Urine

5504

27641

1.78

300.58

2.3

2.0

0.02

estimate

0.17

937

5809

(3020564) Creatinine [Moles/volume] in Serum or Plasma

39247

311886

2.50

295.27

27.8

19.0

79.07

76.68

umol/l

28.70

38868

308496

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2153

7696

2.43

294.64

1.4

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

39044

309660

2.38

293.12

15.9

11.4

26.46

26.45

u/l

0.03

38121

301254

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4461

21314

1.86

285.68

4.2

3.9

91.11

88.60

ng/l

0.86

3761

18537

(3018418) pH of Serum or Plasma

13879

88482

1.49

280.00

4.9

4.2

7.40

1.72

10274

62464

(3020682) Albumin/Creatinine [Ratio] in Urine

15090

98059

1.47

275.14

4.4

4.1

8.97

7.96

mg/mmol

1.54

8905

61024

(3000494) Fungus identified in Specimen by Culture

6556

35352

1.67

274.92

1.6

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

5228

26692

1.75

267.17

2.9

2.4

36.46

49.71

u/l

2.04

4398

22602

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

35649

275618

1.70

267.03

5.0

4.2

1.33

1.29

mmol/l

23.82

32749

256038

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6157

32925

1.68

265.58

3.9

4.7

233.09

245.05

u/l

10.81

5774

31379

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

17798

119908

1.44

265.47

4.6

3.6

1.51

0.51

estimate

1.72

3992

27074

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2602

10592

2.14

261.45

2.1

2.0

—

(3009508) Creatinine [Moles/volume] in Urine

15683

103559

1.45

258.03

3.6

3.4

7.39

7.71

mmol/l

14.54

12839

88275

(3014051) Protein [Presence] in Urine by Test strip

13306

85161

1.47

257.64

3.4

2.8

0.02

0.08

5.87

227

1861

(3012516) Albumin [Mass/volume] in Urine

14748

96413

1.45

255.03

3.7

3.5

48.16

46.45

mg/l

0.34

8824

61313

(3045424) Erythrocytes [Presence] in Urine

3169

14019

1.98

254.20

2.2

2.1

0.04

0.14

estimate

0.71

708

4689

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

37481

294920

1.85

249.36

6.8

5.6

2.67

2.74

mmol/l

45.12

34785

276683

(3002582) Erythrocytes [#/volume] in Urine

14733

96592

1.45

249.29

4.0

3.3

66.51

86.05

e6/l

1.09

11661

72971

(3029937) Albumin [Presence] in Urine by Test strip

13455

86774

1.46

248.04

4.8

3.9

0.00

estimate

0.61

4497

30382

(3018095) Leukocytes [#/volume] in Urine

16539

110881

1.43

247.32

4.8

3.8

71.98

102.62

e6/l

6.78

12285

77125

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1143

3230

3.04

245.68

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1160

3307

3.01

245.58

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

1177

3386

2.99

245.28

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

37082

291111

1.79

244.13

6.0

5.0

4.59

4.67

mmol/l

41.41

34594

274070

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1139

3226

3.03

243.86

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

36914

289426

1.77

243.85

6.0

4.9

1.44

1.46

mmol/l

20.14

34226

271089

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2196

8636

2.21

240.00

1.3

32.81

40.54

u/ml

0.62

108

465

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1096

3064

3.07

239.92

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1097

3070

3.07

239.71

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1090

3061

3.06

236.76

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

10609

65810

1.48

236.00

3.1

2.7

5.11

5.57

e6/l

3.04

9722

59870

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4147

20588

1.78

231.21

2.6

2.4

22.50

21.28

au/ml

0.37

428

2357

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2068

8057

2.23

231.02

1.4

1.3

8.15

7.84

u/ml

0.07

343

1119

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2067

8073

2.22

229.50

1.4

1.3

6.06

5.98

u/ml

0.01

223

700

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2363

9753

2.11

228.24

2.0

1.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

1069

3049

3.01

226.01

2.4

1.9

23.38

26.99

mg/l

1.30

368

1144

(3041096) Erythrocytes [Presence] in Urine by Automated

13206

86178

1.43

222.21

3.9

3.1

0.43

0.25

estimate

0.63

3885

26300

(3033658) Prothrombin time (PT) actual/Normal

11783

75331

1.45

221.39

4.8

3.9

91.43

90.21

5.92

11517

73673

(3025941) Bacteria identified in Stool by Culture

3293

15464

1.86

219.62

1.3

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4525

23510

1.70

213.63

2.4

2.7

66.51

66.48

g/l

0.11

4123

21640

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3821

18979

1.77

211.61

1.4

1.3

46.29

53.23

au/ml

1.15

196

1277

(3026782) Osmolality of Urine

9049

55559

1.48

207.08

3.4

2.8

519.94

535.91

mosm/kgh2o

8.97

7964

48753

(3042936) Bacteria identified in Isolate by Culture

7092

41522

1.53

203.62

2.2

2.0

—

(3030467) Casts [#/volume] in Urine by Automated count

12705

83374

1.41

202.42

3.9

3.2

0.33

0.43

e6/l

6.34

9670

60384

(3022621) pH of Urine by Test strip

4382

22947

1.68

200.01

2.9

2.4

6.06

0.05

2663

15320

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1805

7048

2.21

199.99

1.3

11.29

12.58

u/ml

0.08

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1749

6744

2.24

199.79

1.3

1.2

6.20

5.33

u/ml

0.13

120

428

(3007853) Bacteria identified in Skin by Aerobe culture

6066

34506

1.57

197.62

1.9

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6179

35404

1.55

194.67

2.1

1.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

2651

12147

1.90

189.71

1.9

1.8

6.99

7.08

iu/ml

0.05

589

2843

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

950

2826

2.88

186.23

1.2

45.80

47.52

u/ml

0.06

135

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2165

9359

2.00

183.50

3.0

2.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1212

4126

2.52

182.80

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

841

2361

3.04

182.55

1.2

65.50

72.89

u/ml

0.21

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2632

12195

1.88

181.75

1.7

1.58

1.55

g/l

1.11

2250

10429

(36304419) Bacteria [Presence] in Urine

12010

79300

1.39

179.35

3.8

3.1

1.65

255.48

estimate

0.94

328

(3034770) Mitochondria Ab [Titer] in Serum

1841

7629

2.08

174.92

1.2

747.09

1021.92

titre

1.09

213

(3007566) Smooth muscle Ab [Titer] in Serum

1861

7768

2.07

173.41

1.2

94.81

127.42

titre

1.34

162

745

(3007461) Platelets [#/volume] in Blood

39476

320004

2.14

172.92

33.6

22.3

254.42

252.09

e9/l

10.31

39007

313353

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

39478

320126

2.13

170.85

34.1

22.7

40.24

41.02

7.57

39178

316829

(3024731) MCV [Entitic mean volume] in Red Blood Cells

39476

320123

2.13

170.45

33.4

22.2

91.03

91.05

0.39

39190

316957

(3035941) MCH [Entitic mass]

39474

320108

2.13

170.29

33.4

22.2

30.25

30.33

16.21

39186

316949

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2205

9842

1.94

170.15

2.8

3.0

24.54

24.73

mmol/l

1.58

2163

9670

(3010813) Leukocytes [#/volume] in Blood

39480

320185

2.13

170.08

33.6

22.3

6.79

6.70

e9/l

9.01

38910

312474

(3026361) Erythrocytes [#/volume] in Blood

39476

320146

2.13

169.97

33.5

22.3

4.47

4.51

e12/l

60.39

38908

312446

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2899

14134

1.78

169.34

1.1

1.39

7.51

u/ml

1.41

155

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1748

7197

2.09

168.84

1.1

6.76

5.18

eliau/ml

0.43

159

992

(3000963) Hemoglobin [Mass/volume] in Blood

39477

320212

2.12

168.83

33.8

22.5

134.10

135.95

g/l

123.25

39188

317092

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

9114

57961

1.42

166.90

2.8

3.0

2.44

2.45

mmol/l

5.06

8012

52159

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

17835

126376

1.34

165.28

2.0

1.9

1.41

1.36

mmol/l

9.91

14513

106910

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2440

11405

1.85

163.39

1.3

1.2

1.09

0.74

u/ml

0.61

187

912

(3019150) Specific gravity of Urine by Refractometry

10544

69022

1.39

162.30

4.8

3.8

1.15

kg/l

0.01

7420

45118

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5116

29252

1.54

159.78

3.4

4.5

15.56

28.75

ug/l

3.26

4059

23636

(3020961) Endomysium IgA Ab [Titer] in Serum

2748

13478

1.77

156.86

1.2

1.1

261.26

190.72

titre

0.47

368

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4148

22720

1.60

155.93

2.6

2.2

5.89

7.71

ug/l

8.45

3530

20001

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2562

12332

1.80

155.77

1.9

2.1

39.57

39.64

u/l

0.06

2287

11048

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1116

3943

2.42

155.31

1.2

17.19

14.79

u/ml

0.17

144

(3038026) Centromere Ab [Units/volume] in Serum

718

2025

3.02

154.57

1.2

46.67

57.14

u/ml

0.38

124

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3268

16953

1.68

152.28

1.9

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2517

12161

1.79

150.98

1.4

1.6

8.98

15.95

iu/ml

1.84

335

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3958

21645

1.60

149.39

3.3

2.9

167.71

197.57

ng/l

4.16

3570

19853

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7166

44522

1.43

146.60

2.2

2.1

29.44

29.62

1.57

6927

43361

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1804

7925

1.96

145.35

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

719

2105

2.91

144.96

1.3

1.18

2.14

u/ml

2.54

433

1189

(40758558) Short blood count panel - Blood

13059

89610

1.34

144.70

6.5

6.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1220

4658

2.24

142.12

1.5

1.6

0.67

0.79

g/l

3.61

928

3626

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2154

10155

1.83

139.76

2.1

2.3

431.39

574.15

ug/l

1.16

2036

9578

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

468

1072

3.71

139.67

1.1

7.12

8.85

u/ml

0.50

186

(3020779) Urea [Moles/volume] in Serum or Plasma

4483

25626

1.53

138.68

8.9

7.2

9.80

9.75

mmol/l

0.18

4309

24487

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1966

9104

1.86

134.95

1.8

1.7

1.18

1.19

g/l

1.29

1876

8739

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2158

10317

1.81

133.63

1.3

—

(4024509) Urine culture

2524

12631

1.73

133.57

2.1

1.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2314

11302

1.77

133.32

2.1

2.4

3.61

3.74

g/l

3.03

2073

10359

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1917

8846

1.87

133.00

1.8

1.7

0.23

0.24

g/l

2.70

1822

8459

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2318

11339

1.77

132.83

2.1

2.4

7.35

7.36

g/l

0.09

2076

10388

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2313

11327

1.76

132.02

2.1

2.4

4.24

4.21

g/l

0.94

2071

10389

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

7476

47646

1.39

130.25

3.7

3.0

2.86

2.82

e6/l

0.10

3896

22669

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5527

33459

1.45

128.11

2.2

1.8

—

(40768443) Skin Pathology biopsy report

2611

13349

1.69

127.62

1.3

1.2

—

(4062490) Immunoglobulin typing, IgG

823

2807

2.50

123.41

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

600

1739

2.94

123.16

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

595

1717

2.95

123.08

1.3

1.2

—

(3003129) Base excess in Capillary blood by calculation

897

3202

2.39

121.91

2.1

0.50

0.48

mmol/l

0.05

861

3082

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

8010

52132

1.37

121.54

3.5

2.9

1.00

1.15

e6/l

1.32

4450

27263

(3028192) IgG subclass 2 [Mass/volume] in Serum

828

2867

2.46

120.25

1.4

2.87

2.94

g/l

0.49

591

2069

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2177

10755

1.75

120.24

2.1

2.4

2.77

2.90

g/l

7.85

1934

9805

(3012544) pH of Venous blood

4904

29339

1.46

120.23

4.7

3.9

7.38

0.47

2875

16709

(3003396) Base excess in Arterial blood by calculation

5489

33552

1.44

120.10

8.2

7.6

0.97

0.94

mmol/l

0.19

4599

27779

(3019977) pH of Arterial blood

5525

33813

1.44

120.10

8.3

7.6

7.42

3.29

3079

18219

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5521

33794

1.44

119.88

8.3

7.6

5.05

5.11

kpa

4.40

5294

32568

(3024139) IgG subclass 3 [Mass/volume] in Serum

827

2866

2.46

119.88

1.4

0.37

0.41

g/l

1.89

592

2068

(3011397) Hemoglobin [Presence] in Urine by Test strip

10569

71835

1.32

119.76

4.5

3.6

0.14

0.31

1.17

673

(3027135) IgG subclass 1 [Mass/volume] in Serum

827

2868

2.46

119.70

1.4

6.37

6.80

g/l

2.61

590

2071

(3027801) Oxygen [Partial pressure] in Arterial blood

5515

33780

1.43

119.26

8.3

7.6

11.97

12.63

kpa

18.23

5288

32532

(3017143) Hepatitis C virus Ab [Presence] in Serum

5455

33377

1.44

118.58

1.7

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1034

3982

2.22

117.84

1.5

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1724

7996

1.85

117.45

1.5

18.52

13.75

iu/ml

0.55

195

(3002032) Base excess in Venous blood by calculation

4715

28145

1.47

116.67

4.8

3.9

1.77

1.80

mmol/l

0.21

4201

24715

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1238

5141

2.06

116.36

1.2

1.3

114.55

140.18

titre

0.17

114

(3030981) Hyaline casts [#/volume] in Urine by Automated count

4135

24058

1.50

116.29

2.7

2.4

0.32

0.41

e6/l

2.98

3954

22965

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1227

5101

2.06

114.97

1.2

1.3

265.26

292.83

titre

0.17

404

(3014576) Chloride [Moles/volume] in Serum or Plasma

6350

40141

1.39

114.26

8.2

7.1

104.14

104.40

mmol/l

4.15

6345

40122

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5376

33023

1.43

113.96

7.4

6.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1572

7152

1.89

113.66

1.7

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3410

19139

1.55

113.29

3.2

3.6

4.47

4.51

pmol/l

1.18

2988

17346

(3014111) Lactate [Moles/volume] in Serum or Plasma

4425

26291

1.47

111.80

8.2

7.6

1.32

1.33

mmol/l

0.39

4328

25802

(3016502) Oxygen saturation in Arterial blood

4940

29987

1.44

111.51

8.6

7.9

95.57

95.63

0.25

4774

28988

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2305

11806

1.68

111.45

1.8

1.7

0.35

0.30

mg/l

2.82

1112

5700

(3023419) Bacteria identified in Sputum by Culture

908

3419

2.27

109.19

3.0

2.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4776

29019

1.44

106.90

4.8

3.8

5.80

5.83

kpa

1.18

4665

28318

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5720

35908

1.40

106.44

1.9

1.7

1.52

1.44

14.33

4922

31861

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1442

6527

1.89

105.82

1.3

1.2

43.02

44.58

u/ml

0.12

133

575

(3037121) Protein [Mass/volume] in Urine

1919

9487

1.74

105.42

3.1

3.5

903.66

520.99

mg/l

0.82

730

4489

(3044889) 12 lead EKG panel

26961

208016

1.27

105.32

4.8

3.9

1.64

3292.81

1.54

405

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1970

9837

1.72

104.41

2.2

2.6

0.68

0.85

g/l

1.40

1656

8483

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1573

7384

1.83

102.91

1.8

1.6

—

(3017181) Myelocytes/Leukocytes in Blood

4452

26921

1.44

101.89

4.7

4.4

0.89

0.97

0.83

1459

7790

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

957

3812

2.14

100.23

1.1

1.51

1.50

g/l

0.27

867

3508

(3002179) Metamyelocytes/Leukocytes in Blood

4265

25664

1.45

100.09

4.5

4.2

0.61

0.72

3.04

1449

7392

(3014765) Yersinia sp identified in Stool by Organism specific culture

1563

7396

1.81

99.58

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1565

7414

1.81

99.33

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1555

7353

1.81

99.30

1.2

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1933

9753

1.70

98.54

2.0

2.4

9.96

10.20

g/l

1.54

1667

8721

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1327

6004

1.89

97.43

1.5

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1399

6450

1.86

96.88

1.6

1.4

—

(3021440) Promyelocytes/Leukocytes in Blood

4269

25839

1.44

96.86

4.7

4.4

0.09

0.13

2.89

1284

6746

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

680

2378

2.43

96.67

1.2

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1597

7683

1.78

96.25

1.2

4.05

3.77

0.47

167

1166

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3539

20783

1.48

93.87

1.3

1.2

110.28

142.20

u/ml

4.44

1211

7986

(3044927) Protein electrophoresis panel - Urine

669

2409

2.36

89.18

1.2

—

(3003181) Sodium [Moles/volume] in Urine

1120

4938

1.94

88.81

1.5

1.4

61.40

62.57

mmol/l

0.40

902

3910

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4530

28142

1.40

88.20

9.2

8.4

121.13

122.16

g/l

2.74

4427

27510

(3042631) Mycobacterium sp identified in Specimen

879

3560

2.11

88.18

2.8

2.6

—

(4146454) Self-monitoring of blood glucose

752

2887

2.22

86.32

2.9

2.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2100

11231

1.61

85.07

2.0

1.9

2.10

2.19

ug/l

0.12

1831

9964

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1580

7852

1.72

84.90

2.0

2.2

11.50

11.40

mg/l

0.15

1450

7399

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

6686

44380

1.32

84.75

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1176

5353

1.88

84.67

1.6

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1835

9505

1.66

84.48

3.0

3.6

48.13

41.39

mg/l

0.44

1585

8029

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1798

9270

1.66

84.27

1.6

9.06

4.71

iu/ml

0.43

318

1669

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

954

4053

2.01

84.12

1.3

0.26

0.22

nmol/l

0.20

265

(3034860) Kappa light chains.free [Mass/volume] in Serum

1836

9522

1.65

84.11

3.0

3.6

51.22

59.12

mg/l

0.53

1588

8038

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

817

3284

2.12

83.58

1.2

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

938

3980

2.01

83.00

1.3

0.58

1.55

nmol/l

1.13

911

3855

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1258

5895

1.82

82.60

7.1

5.3

740.69

1858.96

iu/ml

0.72

204

807

(3023183) Ammonium ion [Moles/volume] in Plasma

1225

5703

1.84

82.14

2.8

2.3

32.21

32.71

umol/l

0.34

1094

5122

(3024354) Oxygen [Partial pressure] in Venous blood

3940

24238

1.41

80.72

4.1

3.3

4.61

4.58

kpa

0.44

3843

23589

(3002256) Pathology report gross observation

6153

40640

1.33

80.27

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1724

8904

1.66

80.20

1.3

—

(3025159) Blasts/Leukocytes in Blood

4210

26246

1.39

79.73

4.9

4.6

0.19

0.29

0.53

1201

6518

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2870

16739

1.48

78.16

9.9

9.8

16.01

16.19

2.93

2776

16158

(3047181) Lactate [Moles/volume] in Blood

1633

8396

1.67

77.26

5.5

1.30

1.31

mmol/l

0.18

1458

7453

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1211

5728

1.81

77.08

2.9

3.6

691.09

1116.05

u/ml

0.58

1077

5197

(4015189) Microbial culture of sputum

251

567

3.75

76.61

2.3

2.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1158

5424

1.82

76.11

1.5

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2982

17615

1.46

76.02

3.9

3.3

128.48

130.50

g/l

5.17

2867

17159

(3008898) HLA-B27 [Presence]

1883

10168

1.59

73.04

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

516

1812

2.42

72.78

2.7

3.7

94.59

153.54

nmol/l

3.78

502

1790

(4035726) Immunohistochemistry procedure

4082

25779

1.37

70.91

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

918

4089

1.91

70.58

1.1

2.78

2.80

0.02

119

723

(3017354) Segmented neutrophils/Leukocytes in Blood

721

2956

2.07

70.07

3.9

3.4

56.98

57.43

0.21

610

2539

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

403

1285

2.66

69.42

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

942

4276

1.88

68.37

1.3

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

808

3489

1.97

68.05

1.3

0.18

0.21

nmol/l

1.50

631

2756

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

565

2128

2.26

67.97

1.1

286.10

426.38

mg/l

0.53

491

1971

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1600

8455

1.62

67.82

2.9

3.5

3.52

5.42

ratio

0.61

969

4765

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

414

1362

2.58

67.02

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

414

1362

2.58

67.02

1.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

414

1362

2.58

67.02

1.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

414

1364

2.57

66.82

1.7

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2822

16892

1.44

66.73

4.9

4.1

24.27

24.23

mmol/l

0.34

2789

16675

(3016244) Insulin [Units/volume] in Serum or Plasma

476

1677

2.41

66.70

2.8

3.2

25.56

25.84

mu/l

0.06

451

1579

(46235355) HIV 1 and 2 tests - Meaningful Use set

7549

52336

1.26

66.27

2.0

1.9

—

(4094501) Cardiovascular stress test using bicycle ergometer

1561

8247

1.62

66.22

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2931

17691

1.43

66.20

7.2

6.7

24.51

24.57

mmol/l

0.39

2805

16953

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1370

7003

1.67

66.17

2.4

2.2

130.12

130.85

g/l

0.47

1024

5438

(21494755) Public health laboratory ask at order entry panel

2628

30917

0.70

65.88

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2531

14896

1.46

65.42

3.6

2.9

1.28

1.25

0.68

2526

14827

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

932

4281

1.85

65.19

1.5

1.4

—

(3004809) Band form neutrophils/Leukocytes in Blood

991

4647

1.82

64.87

3.8

3.4

1.35

1.56

1.05

865

4179

(3004716) Salmonella sp identified in Stool by Organism specific culture

2340

13594

1.48

64.62

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

699

2941

2.02

63.35

1.2

59.35

64.03

u/l

0.53

624

2587

(3017315) Amylase [Enzymatic activity/volume] in Urine

401

1338

2.54

63.10

1.2

286.46

333.35

u/l

0.25

364

1257

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1023

4889

1.78

62.88

1.8

1.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1079

5240

1.76

62.78

2.0

1.9

4.89

5.22

mmol/24h

1.71

929

4731

(3007930) Methemoglobin/Hemoglobin.total in Blood

2061

11743

1.50

62.57

5.5

4.9

0.88

0.87

0.39

1960

11105

(3000475) Leukocytes [#/volume] in Synovial fluid

1388

7236

1.64

62.08

1.7

1.6

10368.38

13723.67

e6/l

2.99

988

5171

(3027273) Bicarbonate [Moles/volume] in Venous blood

2185

12627

1.48

61.88

4.2

3.3

25.17

25.31

mmol/l

1.11

2110

12203

(3028626) Oxygen [Partial pressure] in Capillary blood

1428

7508

1.63

61.73

4.3

3.5

8.40

8.32

kpa

1.00

1397

7321

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3202

19862

1.39

61.61

9.2

8.1

24.89

24.78

mmol/l

0.95

3183

19705

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2228

12940

1.48

61.53

5.3

4.7

1.63

0.06

2122

12282

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

621

2539

2.08

60.84

3.9

3.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

572

2269

2.14

60.62

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

572

2269

2.14

60.62

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

572

2269

2.14

60.62

1.6

—

(3021589) Normoblasts [#/volume] in Blood

17761

135173

1.19

60.29

13.8

11.1

0.00

e9/l

0.36

14698

110053

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2859

17462

1.41

60.19

10.2

9.6

24.41

24.30

mmol/l

1.07

2787

17081

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1559

8429

1.58

59.99

2.0

2.4

0.04

0.03

g/l

0.19

1392

7602

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1157

5805

1.70

59.90

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

968

4638

1.78

58.99

3.3

2.8

3594.29

5551.62

u/ml

0.22

245

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

503

1919

2.22

58.73

2.3

2.8

223.74

239.83

e6/l

0.84

434

1614

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

353

1148

2.61

58.56

1.5

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

700

3032

1.96

58.48

2.9

3.6

6.78

9.06

nmol/l

0.32

669

2950

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

353

1149

2.60

58.46

1.5

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4448

29243

1.32

58.28

3.8

3.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

672

2874

1.99

58.21

1.7

—

(3033099) Centromere Ab [Titer] in Serum

249

671

3.14

58.16

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1154

5864

1.68

56.97

1.3

60.00

43.47

u/ml

0.22

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

981

4782

1.75

56.33

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

449

1665

2.29

56.11

1.4

1.3

—

(3006462) Nitrate [Presence] in Urine

346

1142

2.57

55.74

4.1

2.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

625

2650

2.00

55.49

1.8

1.7

—

(3021901) Oxygen saturation in Capillary blood

1174

6034

1.66

55.49

3.1

3.0

90.57

90.19

1.26

1142

5865

(4211845) Urine protein measurement

367

1258

2.47

54.66

4.0

2.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

441

1643

2.28

54.53

1.4

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

276

821

2.85

54.34

1.3

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

355

1204

2.50

54.08

1.8

1.98

1.96

umol/l

0.15

324

1100

(3032057) Clostridioides difficile [Presence] in Stool

186

437

3.60

53.82

1.9

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1166

6031

1.65

53.76

1.7

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

428

1584

2.29

53.76

1.5

1.6

6.81

8.90

ug/l

1.86

399

1446

(40761536) Microorganisms panel - Urine sediment

3686

23859

1.33

53.60

4.9

3.8

—

(44806118) Parainfluenza type 4 nucleic acid detection

774

3569

1.84

53.52

1.8

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

774

3570

1.84

53.47

1.8

1.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

511

2038

2.13

53.47

1.8

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

774

3572

1.84

53.38

1.8

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

774

3575

1.84

53.23

1.8

1.4

—

(3037756) Immunofixation for Serum or Plasma

1121

5756

1.66

53.18

1.8

1.7

—

(3021788) Differential panel - Synovial fluid

1081

5519

1.67

52.42

1.6

1.5

1.00

0.96

—

(40762887) Creatinine [Moles/volume] in Blood

102

150

5.74

52.14

1.5

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1466

8071

1.55

52.06

2.0

2.4

0.00

g/l

0.37

1283

7064

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1217

6441

1.61

51.17

1.2

1.1

1.49

2.02

u/ml

1.30

648

3402

(3052851) Hemolysis interference index of Serum or Plasma

1423

7823

1.55

50.85

3.4

3.1

2.10

2.30

index

0.28

709

3946

(3011412) CD3 cells [#/volume] in Blood

618

2697

1.95

50.57

2.2

2.5

1290.81

1197.03

e6/l

1.06

547

2360

(3039162) Centromere protein B Ab [Units/volume] in Serum

769

3609

1.81

50.25

1.4

1.2

84.47

46.08

u/ml

3.57

191

(3010370) Gastrin [Moles/volume] in Serum or Plasma

152

326

3.94

50.03

1.7

1.8

37.95

36.97

pmol/l

0.05

123

272

(3000330) Specific gravity of Urine by Test strip

2310

14031

1.41

49.92

3.9

3.2

1.02

ratio

5.47

2072

12622

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1371

7509

1.56

49.81

2.0

2.5

0.00

g/l

-0.00

1279

7048

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

675

3052

1.88

49.66

1.2

1.1

1.80

2.03

iu/ml

0.13

(3008295) Osmolality of Serum or Plasma

653

2929

1.89

49.24

1.6

1.4

277.31

279.41

mosm/kgh2o

1.40

509

2234

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

992

5034

1.68

49.23

1.2

1.1

17.27

15.12

au/ml

0.36

189

1358

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1726

9962

1.48

49.00

3.0

3.7

419.29

2386.45

u/ml

2.13

1472

8635

(3006653) Thiamine [Moles/volume] in Blood

380

1392

2.31

48.93

1.3

1.2

131.56

138.45

nmol/l

2.35

380

1392

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

300

986

2.58

48.82

1.8

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

300

987

2.57

48.72

1.8

2.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

466

1867

2.12

48.24

2.2

2.7

569.76

532.12

e6/l

0.51

391

1481

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

563

2426

1.97

47.82

3.0

2.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3918

25980

1.30

47.58

2.6

2.3

13.11

12.97

nmol/l

0.49

3483

23638

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

300

1001

2.54

47.35

1.8

2.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1415

7892

1.53

47.35

1.5

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

12478

93527

1.18

46.74

6.0

5.4

2.52

3.25

ug/l

3.16

11284

85057

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3442

22478

1.32

46.71

1.5

—

(1616796) Gas panel - Central venous blood

1215

6571

1.58

46.64

3.9

3.6

—

(3010421) pH of Blood

1594

9147

1.49

46.55

4.0

3.5

7.41

0.29

1576

9009

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

687

3191

1.83

46.45

1.8

1.7

360.88

365.01

mu/l

0.08

538

2580

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

419

1637

2.17

46.26

1.4

7.01

5.89

u/l

0.31

351

1424

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1376

7674

1.53

46.05

1.3

1.4

495.95

551.10

mg/l

3.29

1304

7382

(3039000) Anion gap in Blood by calculation

1090

5768

1.61

45.86

6.6

6.5

11.37

11.20

mmol/l

0.93

1000

5202

(3018572) Chloride [Moles/volume] in Blood

1090

5769

1.61

45.83

6.6

6.5

104.80

105.11

mmol/l

1.11

1000

5204

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1463

8293

1.51

45.35

1.9

2.0

9.31

13.17

iu/l

0.26

576

3424

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

341

1237

2.33

44.95

2.1

1.9

85.40

136.23

umol/l

4.21

180

614

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

749

3616

1.76

44.54

2.8

2.6

455.27

818.49

u/ml

0.43

744

3573

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

284

951

2.53

44.53

1.9

1.7

47484.41

16590.81

u/ml

0.41

137

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1098

5864

1.59

44.47

1.5

1.4

18.52

21.71

u/ml

0.38

106

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

917

4698

1.66

43.90

1.4

1.5

12.42

15.06

u/ml

0.25

112

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1042

5526

1.60

43.46

1.3

276.04

256.74

u/ml

1.29

632

3501

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2283

14167

1.38

43.33

5.1

3.8

48.86

47.67

1.49

2257

13974

(3020717) Zinc [Moles/volume] in Serum or Plasma

402

1589

2.14

43.14

1.5

21.01

24.02

umol/l

1.31

374

1465

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

506

2193

1.96

42.33

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4202

28514

1.27

42.22

2.2

2.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

783

3897

1.71

41.81

1.1

2.63

2.95

eliau/ml

0.24

280

1997

(3014007) Fractional oxyhemoglobin in Arterial blood

2970

19287

1.32

41.75

10.9

9.7

93.91

93.99

0.27

2960

19226

(44813793) Dust mix specific IgE antibody measurement

478

2043

1.98

41.62

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1093

5925

1.57

41.54

1.6

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3535

23520

1.29

41.53

4.4

3.8

1.23

mmol/l

1.02

3120

20185

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

323

1186

2.31

41.46

1.8

27.44

29.43

umol/l

2.95

298

1111

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

396

1581

2.12

41.45

1.1

86.66

81.10

u/l

0.54

361

1407

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4536

31211

1.25

40.37

2.3

2.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

390

1577

2.10

39.52

1.1

24.64

22.46

u/l

0.29

352

1403

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

233

755

2.61

39.14

2.6

3.4

1.90

1.78

ratio

0.52

212

691

(3020191) Ethanol [Moles/volume] in Serum or Plasma

526

2375

1.88

38.97

1.8

1.4

1.34

1.25

promille

0.66

429

1874

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

512

2295

1.89

38.80

1.3

2.01

2.17

mmol/l

1.97

473

2132

(3026250) Tacrolimus [Mass/volume] in Blood

311

1157

2.28

38.76

42.7

40.5

7.29

7.21

ug/l

0.29

281

1044

(3045683) HLA typing for celiac disease panel - Blood or Tissue

391

1595

2.08

38.73

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1035

5632

1.56

38.70

1.1

4.15

4.69

u/ml

0.56

519

2956

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

292

1058

2.34

38.68

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

590

2779

1.80

38.20

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

396

1636

2.05

37.93

1.6

8.23

6.79

u/l

1.07

324

1294

(3006270) Folate [Moles/volume] in Blood

464

2029

1.94

37.88

1.3

1.1

340.57

378.95

nmol/l

3.83

403

1706

(3013290) Carbon dioxide [Partial pressure] in Blood

1084

6000

1.54

37.57

4.2

3.8

4.97

5.00

kpa

0.47

1065

5853

(3012501) Base excess in Blood by calculation

1083

5999

1.54

37.40

4.2

3.8

2.45

2.49

mmol/l

0.16

746

4050

(3044290) Cell count panel - Cerebral spinal fluid

1139

6384

1.52

37.25

1.3

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2850

18691

1.31

37.17

11.2

9.8

0.64

0.63

0.40

2830

18601

(3027315) Oxygen [Partial pressure] in Blood

1087

6036

1.53

37.12

4.2

3.8

8.71

8.64

kpa

0.68

1068

5888

(3027923) C peptide [Moles/volume] in Serum or Plasma

383

1577

2.06

37.03

1.6

1.5

1.28

1.30

nmol/l

0.09

273

1196

(40767503) Oxygen content in Capillary blood by calculation

1104

6156

1.53

36.99

2.9

2.6

16.65

16.60

0.24

1085

6013

(3008401) Mugwort IgE Ab [Units/volume] in Serum

992

5404

1.56

36.93

1.1

0.74

1.03

u/ml

1.10

413

2367

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1202

6832

1.50

36.77

1.2

1.3

3.76

3.74

mmol/l

0.21

1124

6494

(3006571) Granulocytes/Leukocytes in Synovial fluid

696

3479

1.70

36.63

1.6

54.18

57.45

1.26

446

2202

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2925

19286

1.30

36.63

10.9

9.5

1.31

1.32

0.31

2904

19178

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

236

796

2.51

36.57

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

288

1065

2.29

36.44

32.6

29.9

111.78

116.18

ug/l

0.52

233

896

(3006922) Hepatitis E virus Ab [Presence] in Serum

490

2213

1.88

36.32

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

282

1037

2.30

36.15

2.0

2.1

40.28

40.52

g/l

0.26

282

1037

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

520

2397

1.84

36.14

1.2

111.90

110.78

pmol/l

0.14

520

2397

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

3541

23967

1.27

36.03

3.0

2.7

66.21

67.27

ml/min/173m2

0.85

1587

9889

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

685

3427

1.70

35.95

1.7

1.9

6182.86

3146.28

titre

0.28

137

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

263

942

2.36

35.80

1.3

1.2

110.60

110.93

0.06

236

852

(3010503) CD19 cells [#/volume] in Blood

393

1662

2.00

35.34

2.3

2.7

304.00

325.14

e6/l

0.05

384

1612

(3023430) Cat dander IgE Ab [Units/volume] in Serum

836

4425

1.60

35.20

1.1

3.18

4.62

u/ml

1.85

357

1968

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

725

3705

1.66

35.13

1.8

1.5

—

(3024928) Oxygen saturation in Venous blood

1245

7193

1.47

35.12

3.7

3.3

62.39

62.27

0.07

1195

6942

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

756

3907

1.64

35.06

6.6

6.1

11.93

11.59

mg/l

1.29

703

3633

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1531

9200

1.42

35.01

3.3

3.2

0.35

0.36

iu/ml

0.58

806

5084

(3037692) Legionella sp identified in Specimen by Organism specific culture

249

881

2.39

34.85

1.7

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

836

4442

1.60

34.65

2.1

1.8

1.73

1.74

mmol/l

0.03

822

4307

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

504

2332

1.83

34.64

2.3

2.4

19.00

18.19

nmol/l

1.05

469

2212

(3029634) Reagin Ab [Titer] in Serum by VDRL

772

4038

1.62

34.14

2.1

2.2

14.36

8.54

titre

0.42

119

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

858

4621

1.58

33.59

1.4

1.3

27.66

29.53

u/l

0.83

662

3818

(3014271) Vancomycin [Susceptibility]

302

1184

2.16

33.23

2.8

2.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

956

5300

1.53

32.92

1.1

1.04

1.74

u/ml

2.87

462

2637

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

175

539

2.74

32.54

1.3

1.18

mmol/l

0.00

175

539

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

203

682

2.52

31.79

1.7

1.6

0.36

0.39

ug/l

0.81

143

495

(3016650) Hepatitis A virus Ab [Presence] in Serum

881

4838

1.55

31.69

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1444

8746

1.41

31.57

1.5

1.4

10.70

10.57

u/l

0.13

1140

7038

(3014133) Dog dander IgE Ab [Units/volume] in Serum

860

4702

1.55

31.55

1.1

2.97

3.99

u/ml

0.65

417

2309

(3040151) Glucose [Moles/volume] in Capillary blood

640

3260

1.67

31.45

6.0

6.1

7.35

7.26

mmol/l

0.13

508

2712

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

267

1020

2.21

31.36

1.3

1.2

0.30

0.31

g/l

0.66

223

815

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1487

9063

1.40

31.34

3.7

1.61

1.49

mg/l

5.42

1364

8290

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

469

2200

1.81

30.89

1.1

6.98

8.27

iu/ml

0.57

102

600

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

891

4935

1.53

30.84

1.3

30.16

29.97

u/l

0.02

763

4301

(3011985) Renin [Units/volume] in Plasma

802

4346

1.57

30.62

1.6

1.5

65.57

64.95

mu/l

0.03

715

3925

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

294

1180

2.11

30.52

2.2

2.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

382

1687

1.92

30.40

1.3

1.2

90.94

92.27

u/l

0.07

324

1455

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

957

5404

1.50

30.26

1.6

1.5

151.64

148.36

au/ml

0.34

232

1639

(3000093) Morphology [Interpretation] in Blood Narrative

534

2618

1.73

30.24

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

453

2118

1.81

30.17

1.8

2.2

14.04

15.29

1.82

442

2065

(3020491) Glucose [Moles/volume] in Blood

423

1938

1.85

30.08

1.7

1.8

6.62

6.85

mmol/l

1.07

290

1399

(40768441) Liver Pathology biopsy report

433

2010

1.82

29.53

1.4

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

651

3390

1.63

29.37

2.0

1.8

90.25

89.71

1.51

644

3332

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

371

1644

1.91

29.25

1.3

1.2

26.15

25.93

u/l

0.02

311

1391

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1018

5864

1.48

29.20

2.2

1.8

0.91

0.86

nmol/l

1.04

833

5002

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1250

7486

1.42

29.15

2.0

1.9

198.13

201.31

pmol/l

0.51

1191

7131

(3020876) Protein [Mass/time] in 24 hour Urine

668

3509

1.61

29.10

2.4

2.5

1.25

1.23

g/24h

0.07

380

2117

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1382

8434

1.39

28.91

1.8

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

953

11660

0.68

28.86

1.1

0.63

0.62

ratio

0.03

130

1469

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

239

904

2.24

28.80

1.1

1.0

7.28

9.49

u/ml

0.95

130

599

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

676

3577

1.60

28.59

1.7

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1016

5886

1.47

28.31

3.7

3.3

9.54

9.04

pmol/l

0.66

1016

5881

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

350

1541

1.92

28.16

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

205

733

2.36

28.15

1.8

1.6

9.51

9.09

ug/l

0.77

205

733

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

381

1727

1.87

28.06

1.1

7.59

5.62

nmol/l

0.36

321

(1175426) CD3 cells/Lymphocytes in Blood

461

2219

1.76

27.89

1.8

2.2

73.67

72.34

1.01

448

2135

(3047352) Trisomy 18 risk [Likelihood] in Fetus

326

5103

0.53

27.73

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

338

5219

0.54

27.45

1.5

1.6

—

(3042733) HLA Ab [Presence] in Serum

225

850

2.24

27.23

5.3

5.2

—

(3016038) Potassium [Moles/volume] in Urine

396

1840

1.82

26.98

1.3

1.2

32.29

34.69

mmol/l

1.43

349

1606

(3005033) Fetal Nuchal fold Thickness US

323

5023

0.54

26.89

1.5

1.30

1.26

0.52

215

3618

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

588

3054

1.63

26.85

1.1

76.24

73.54

au/ml

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

153

487

2.65

26.81

1.1

0.78

umol/24h

0.00

245

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

566

2916

1.65

26.70

1.3

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

216

809

2.26

26.69

1.3

134.97

124.43

nmol/l

0.47

166

574

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1559

9845

1.35

26.35

2.0

1.8

41.91

41.65

nmol/l

0.15

1507

9650

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

404

1904

1.80

26.29

2.4

2.7

0.74

0.68

e9/l

0.73

393

1821

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

313

1359

1.95

26.28

1.5

1.6

2.40

9.20

nmol/l

0.96

258

1133

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

253

1024

2.09

25.79

2.3

2.0

59.26

59.94

ug/l

0.05

247

1003

(3036489) Thrombin time

1758

11348

1.32

25.57

2.2

2.1

21.04

21.05

0.03

1520

10047

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

151

490

2.60

25.50

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1216

7420

1.39

25.48

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2368

15904

1.27

25.42

2.9

3.7

46.99

56.23

u/ml

0.83

2272

15416

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

727

4036

1.53

24.98

1.4

314.27

365.86

pmol/l

0.74

606

3491

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

381

1798

1.79

24.72

1.3

703.16

413.03

titre

0.36

122

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

963

11438

0.70

24.72

1.5

1.6

959.77

1017.25

mu/l

1.21

774

9539

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

495

2515

1.67

24.68

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1561

9962

1.33

24.59

2.4

2.3

4675.13

5297.52

u/l

0.35

497

3908

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

373

1755

1.80

24.45

1.3

35.83

75.64

titre

2.13

133

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

110

309

3.01

24.28

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

850

4904

1.47

24.25

1.2

0.83

1.21

0.68

207

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

239

976

2.07

23.85

2.3

2.1

9.20

9.14

mg/l

0.06

209

793

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

535

2798

1.62

23.83

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

963

5716

1.43

23.66

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

963

5717

1.43

23.63

1.4

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

645

3536

1.55

23.51

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

712

3991

1.51

23.42

1.1

0.40

0.42

u/ml

0.06

239

1232

(3017704) Immunofixation for Urine

316

1432

1.87

23.39

1.8

1.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

317

1438

1.86

23.39

1.7

1.8

1.47

2.93

u/field

2.95

229

1019

(3027231) Wheat IgE Ab [Units/volume] in Serum

157

542

2.45

23.38

1.0

1.1

0.89

2.81

u/ml

0.69

119

483

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1382

8737

1.34

23.21

2.6

191.77

189.23

0.46

1278

8336

(40759836) Histone Ab [Presence] in Serum by Immunoblot

481

2468

1.65

23.13

1.2

—

(3020891) Body temperature

2015

13421

1.28

23.13

5.4

4.3

36.93

36.90

°c

2.56

1995

13294

(3010144) Erythrocytes [#/volume] in Synovial fluid

512

2671

1.62

23.06

1.5

1.4

135045.45

107458.79

e6/l

0.38

311

1800

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1414

8985

1.34

22.95

2.7

3.58

3.61

g/l

0.27

1336

8626

(21494815) CD4 cells/Lymphocytes in Specimen

492

2548

1.64

22.82

2.0

2.3

41.03

38.35

3.16

477

2510

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

160

565

2.39

22.70

1.2

315.11

299.17

pmol/l

0.18

114

424

(3001186) Copper [Moles/volume] in Serum or Plasma

195

750

2.20

22.70

1.2

1.3

16.84

16.64

umol/l

0.20

160

657

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

437

2209

1.67

22.28

1.2

1.1

—

(21494434) Karyotype in Bone marrow

465

2393

1.65

22.13

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

1020

6199

1.40

21.94

3.6

3.1

62.88

62.71

0.09

1014

6174

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

156

554

2.38

21.88

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

232

970

2.02

21.78

2.4

2.7

1.09

1.07

ug/l

0.06

216

930

(3034274) Bile acid [Moles/volume] in Serum --fasting

599

3290

1.54

21.69

2.0

2.1

9.26

7.13

umol/l

0.92

424

2402

(3018333) Ribosomal P Ab [Presence] in Serum

446

2283

1.65

21.68

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

112

342

2.77

21.36

2.4

1.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1100

6800

1.37

21.36

1.3

1.5

28.61

33.56

e6/l

0.16

817

5041

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

468

2439

1.62

21.21

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

9755

75037

1.13

21.20

4.8

4.4

21.91

22.04

0.32

4658

36266

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

782

4562

1.45

21.13

1.3

1.2

3.93

3.77

u/ml

0.15

366

2099

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

307

1425

1.82

21.12

1.5

1647413.89

1798749.69

iu/ml

0.07

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

227

3.20

21.12

1.1

1.0

0.06

0.04

u/ml

0.30

227

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

229

964

2.01

21.11

1.5

1.4

14.97

14.72

pmol/l

0.27

189

812

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

467

2436

1.62

21.09

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

456

2365

1.63

21.07

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

452

2340

1.64

21.04

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

287

1308

1.86

20.94

4.1

3.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

430

2201

1.65

20.93

1.2

181.03

197.00

titre

0.15

350

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1463

9469

1.31

20.90

2.5

2.4

94.85

93.44

1.61

1387

9127

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

429

2196

1.65

20.88

1.2

230.00

146.56

titre

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1107

6886

1.36

20.68

1.3

1.5

2690.90

2035.78

e6/l

0.13

893

5424

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

413

2099

1.67

20.67

1.5

23.73

25.19

u/ml

0.22

405

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

563

3091

1.54

20.46

2.5

21.59

26.42

iu/ml

0.62

307

(3004451) EKG impression Narrative

324

1546

1.77

20.36

1.4

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

423

2174

1.65

20.29

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

539

2945

1.55

20.02

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

354

1746

1.72

19.83

2.4

2.6

1000.53

1021.06

u/ml

0.04

348

1726

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

457

2409

1.61

19.81

1.1

1.2

36.23

44.54

mg/l

3.30

390

2047

(3020911) Cortisol [Moles/time] in 24 hour Urine

230

996

1.95

19.62

1.6

1.4

78.90

194.70

nmol/24h

2.08

230

996

(3018405) Lactate [Moles/volume] in Arterial blood

1404

9117

1.31

19.60

4.4

4.0

1.36

1.38

mmol/l

0.41

1370

8946

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

183

729

2.12

19.59

1.8

1.7

138.15

134.81

au/ml

0.02

101

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

442

2320

1.61

19.51

1.1

268.06

278.52

mg/l

0.31

398

2070

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1138

12673

0.75

19.37

1.2

0.90

0.89

g/l

0.60

1132

12630

(3051611) Lipemic interference index of Serum or Plasma

506

2757

1.55

19.06

3.4

14.08

14.38

index

0.14

260

1562

(3024471) HLA-A [Type]

200

834

2.03

18.99

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

114

374

2.57

18.98

1.1

1.0

0.02

0.37

u/ml

1.88

241

(3023511) Choriogonadotropin [Units/volume] in Urine

788

4707

1.42

18.79

1.4

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

511

6483

0.66

18.74

1.5

60.80

61.70

ug/l

0.16

417

5353

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

330

1625

1.72

18.63

2.2

2.0

100.00

100.16

0.03

304

1543

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

229

1010

1.92

18.54

1.7

1.9

—

(40762814) Titanium [Mass/volume] in Blood

122

419

2.46

18.49

2.5

3.07

3.52

ug/l

0.94

154

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

130

461

2.38

18.39

1.2

1.4

11413.33

171406.60

u/ml

0.48

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

311

1513

1.74

18.34

1.2

—

(3024932) HLA-DR beta [Type]

194

814

2.01

18.14

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

192

807

2.01

17.87

1.3

40.62

40.38

g/l

0.08

441

(3028433) Virus identified in Specimen by Culture

195

825

2.00

17.83

1.3

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

487

6170

0.66

17.76

1.4

1.5

1.16

1.19

ratio

0.30

279

3736

(37021550) Renin [Units/volume] in Plasma --upright

136

500

2.30

17.75

1.2

1.3

63.86

79.39

mu/l

0.30

379

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

487

6169

0.66

17.75

1.4

1.5

1.01

0.95

ratio

1.57

278

3710

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

112

378

2.50

17.63

1.1

1.3

44.65

40.76

mg/l

0.35

324

(4195642) Thrombophilia screening test

722

4299

1.42

17.56

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

486

6143

0.66

17.53

1.4

1.5

1.14

1.16

ratio

0.14

277

3684

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

268

1266

1.79

17.51

1.2

5.72

11.42

u/ml

0.70

134

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

266

1254

1.79

17.50

2.2

2.5

104.08

220.09

ug/l

0.47

254

1201

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

185

774

2.02

17.46

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

185

774

2.02

17.46

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

185

774

2.02

17.46

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

185

774

2.02

17.46

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

474

2605

1.54

17.24

1.4

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

265

1254

1.79

17.23

1.1

314.19

478.74

ng/l

0.39

352

(3021387) Prolactin [Units/volume] in Serum or Plasma

1519

10139

1.27

17.17

1.8

1.7

290.02

301.73

mu/l

0.68

1387

9224

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1119

7181

1.32

17.05

1.2

1.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

113

390

2.45

16.99

1.1

1.0

96.05

80.09

ug/l

2.81

315

(3043410) Blood group antigens tested for on Red Blood Cells

169

691

2.07

16.98

1.7

1.8

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

158

3.36

16.86

1.0

0.14

0.78

u/ml

0.84

148

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1599

10763

1.26

16.86

1.8

1.7

4.70

4.21

mg/l

0.56

1301

7950

(3012494) Peanut IgE Ab [Units/volume] in Serum

176

733

2.03

16.84

1.1

3.04

7.90

u/ml

0.48

433

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

484

6072

0.67

16.82

1.4

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

846

5221

1.37

16.70

1.7

1.6

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

237

1099

1.82

16.50

1.9

2.2

29.43

29.27

0.05

227

1048

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

413

2223

1.57

16.49

1.8

2.0

1.94

1.89

u/field

0.08

256

1220

(3050129) First trimester maternal screen panel - Serum or Plasma

641

7592

0.71

16.28

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

278

1357

1.73

16.27

1.3

1.2

159.26

163.12

mmol/24h

0.31

278

1357

(21494890) Protein electrophoresis panel - 24 hour Urine

503

2837

1.50

16.24

1.8

2.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

195

854

1.93

16.20

5.7

6.4

24.49

25.34

mmol/l

2.23

176

783

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

118

427

2.33

16.02

1.9

2.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

108

378

2.41

15.80

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

548

3165

1.47

15.74

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

214

2.92

15.71

1.0

3.00

4.58

u/ml

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.44

15.63

1.1

1.0

0.03

0.04

u/ml

0.24

(1761482) Bacteria [#/volume] in Urine by Culture

1016

6520

1.32

15.52

4.9

3.9

—

(3011436) Histone Ab [Units/volume] in Serum

145

580

2.11

15.49

1.1

—

27.50

u/ml

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

738

4512

1.39

15.46

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

175

751

1.97

15.45

1.1

—

(40768446) Kidney Pathology biopsy report

238

1135

1.77

15.15

1.9

1.6

—

(3038515) Glucose [Moles/volume] in Venous blood

896

5667

1.34

15.14

4.2

3.2

7.46

7.55

mmol/l

0.38

869

5545

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

205

935

1.85

15.09

2.5

2.6

0.61

mmol/l

0.49

205

935

(3027456) Digoxin [Moles/volume] in Serum or Plasma

839

5261

1.35

15.01

3.3

0.81

0.80

nmol/l

0.29

660

4255

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

121

456

2.24

14.99

1.9

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

714

4365

1.39

14.98

1.1

120.78

117.34

2.14

645

3975

(3045142) Bone marrow Pathology biopsy report

551

3218

1.45

14.96

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

279

1397

1.69

14.94

1.8

2.0

144.04

149.79

0.55

261

1330

(3018133) Calcium [Moles/volume] in Urine

141

567

2.10

14.88

1.8

1.9

2.74

2.73

mmol/l

0.02

132

518

(3008037) Lactate [Moles/volume] in Venous blood

1060

6885

1.31

14.86

4.0

3.0

1.50

1.58

mmol/l

2.64

1031

6724

(3020874) Milk IgE Ab [Units/volume] in Serum

357

1913

1.58

14.60

1.0

1.1

1.07

2.91

u/ml

1.14

144

603

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1518

10336

1.25

14.52

2.0

1.8

—

26.01

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

760

4719

1.36

14.50

1.3

1.2

3.19

3.94

u/ml

0.68

297

1786

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

4.78

14.50

1.1

0.22

0.21

g/l

0.40

(3006245) CD3-CD19+ cells/cells in Blood

237

1145

1.75

14.45

2.0

2.4

11.04

10.02

0.50

221

1074

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3715

35595

0.87

14.34

2.0

3.54

3.49

ratio

1.58

2864

27441

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

159

682

1.97

14.11

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

286

1468

1.65

13.98

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

220

3156

0.59

13.94

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

401

2233

1.52

13.84

1.6

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

678

4166

1.38

13.84

1.1

16.73

3.79

—

(4268621) Lupus anticoagulant assay

548

3254

1.43

13.66

2.2

2.3

—

(3024869) Neuronal Ab [Presence] in Serum

126

503

2.11

13.59

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

122

481

2.14

13.59

1.1

3.16

5.95

u/ml

0.40

312

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

336

1807

1.57

13.58

1.6

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1392

9473

1.25

13.40

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

244

1216

1.70

13.36

2.8

5.1

1827.65

2287.31

mg/l

0.13

155

901

(40757373) Influenza virus identified in Isolate

117

457

2.16

13.35

1.8

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

1151

7667

1.27

13.31

4.9

4.3

3.86

3.88

mmol/l

0.68

1137

7609

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

132

541

2.06

13.31

1.3

1.2

16.61

54.23

mg/l

0.84

387

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

205

974

1.78

13.29

3.2

3.6

8.07

8.53

mg/l

0.44

157

781

(3025549) Creatine [Moles/time] in 24 hour Urine

202

2.80

13.27

1.5

1.4

—

12.96

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

310

1646

1.59

13.24

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

270

2.53

13.21

1.4

1.2

5.50

6.47

mmol/l

0.92

140

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

323

1733

1.58

13.20

1.1

1.07

1.06

ratio

0.80

279

1430

(3012565) Volume of 24 hour Urine

276

1427

1.63

13.14

2.2

1883.01

1991.14

1.04

253

1271

(3014148) Varicella zoster virus Ab [Titer] in Serum

642

3946

1.38

13.11

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1195

8014

1.26

13.07

1.2

1.1

—

(3000012) Reticulocyte production index

649

3999

1.37

13.05

2.3

2.2

0.92

0.91

0.21

457

2660

(3033942) Copper [Moles/time] in 24 hour Urine

108

3.51

12.95

1.0

1.4

0.26

0.66

umol/24h

0.97

(3028717) Thiamine [Mass/volume] in Blood

368

2.27

12.75

1.2

63.85

64.51

ug/l

0.12

368

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

316

1703

1.57

12.69

1.6

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

728

4591

1.34

12.63

1.6

1.7

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

2719

26415

0.86

12.63

1.8

1.7

3.47

3.50

mmol/l

0.60

1873

18113

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

373

2091

1.51

12.53

1.3

81.33

80.27

0.11

134

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

145

3.08

12.45

1.4

2.0

162.06

186.07

ug/g

0.54

122

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

456

2673

1.44

12.25

4.6

5.5

79.73

103.07

u/ml

0.43

127

934

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

306

1655

1.56

12.13

1.1

1.11

1.13

u/l

0.18

130

679

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

248

2.52

11.98

1.0

0.08

0.33

u/ml

0.87

154

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

576

3536

1.38

11.90

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

244

2.52

11.89

1.1

1.69

1.79

umol/24h

0.30

244

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

189

911

1.75

11.73

1.1

92.52

88.00

0.88

434

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

548

3348

1.38

11.67

1.1

96.14

97.29

0.46

501

3148

(3000060) B lymphocytes [#/volume] in Blood

182

870

1.77

11.63

1.9

2.3

1.19

0.59

e9/l

0.31

413

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

300

1634

1.55

11.56

1.7

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

333

1857

1.52

11.52

1.1

3.30

4.01

u/ml

0.12

104

452

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

201

993

1.71

11.45

1.2

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

588

3650

1.36

11.36

1.8

2.0

22.65

26.14

ug/l

0.62

573

3591

(44806071) Cardiolipin IgM antibody measurement

382

2.17

11.32

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

279

1505

1.57

11.23

1.8

2.4

195.54

204.85

u/l

1.35

279

1491

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

353

2008

1.49

11.12

1.4

12.80

12.65

u/l

0.16

337

1944

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

385

2.15

11.11

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

192

948

1.71

10.98

1.2

110.78

107.76

0.46

167

880

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1343

9311

1.22

10.93

1.4

1.3

210.73

219.61

miu/ml

0.41

560

4257

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

260

2.40

10.89

1.2

1.89

1.73

iu/ml

0.30

136

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

189

932

1.71

10.87

1.1

90.90

88.74

0.43

438

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

367

2.16

10.84

1.7

1.5

85922.75

289000.65

nmol/l

0.97

318

(3036603) Volume of Urine

383

2229

1.45

10.76

1.7

1.6

1983.15

2006.95

0.12

374

2182

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

179

872

1.73

10.76

2.8

155.50

153.23

au/ml

0.03

132

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

999

6723

1.26

10.69

1.4

145.57

138.36

pmol/l

0.14

974

6571

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

199

1000

1.68

10.69

1.9

2.0

165.65

170.08

0.21

185

957

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

185

913

1.71

10.62

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

157

740

1.79

10.57

1.9

1.4

—

(40762365) Oxygen content in Arterial blood by calculation

393

2.10

10.57

2.2

3.1

15.23

14.84

ml/dl

0.71

364

(3019174) dRVVT (LA screen)

230

2.46

10.38

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

192

964

1.68

10.36

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

122

535

1.92

10.30

2.3

2.6

651.98

296.16

ug/l

0.41

122

535

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

132

595

1.87

10.27

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

259

2.35

10.10

1.0

1.1

0.18

4.69

u/ml

3.00

199

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

265

2.32

10.03

1.0

0.63

0.66

u/ml

0.02

128

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

958

6467

1.25

10.02

2.5

2.4

108.79

103.63

ug/min

0.12

562

3830

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

282

1571

1.52

9.89

1.3

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

259

1419

1.54

9.81

1.2

1.3

63.88

61.39

0.11

173

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

276

1535

1.52

9.76

1.4

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2254

16531

1.16

9.66

1.4

27.22

29.34

iu/l

2.28

1912

14241

(3009871) Measles virus Ab [Titer] in Serum

217

1147

1.60

9.61

1.5

1.6

4788.57

3456.71

titre

1.63

180

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7191

56391

1.09

9.55

3.5

3.1

0.71

0.78

ug/l

7.85

4778

36037

(40761539) Cells [Type] in Urine sediment by Light microscopy

137

641

1.80

9.51

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.82

9.46

1.1

1.4

79.23

31.75

umol/24h

0.46

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

362

2139

1.43

9.45

1.1

18.47

20.12

u/ml

0.31

127

871

(3010015) Selenium [Moles/volume] in Serum or Plasma

295

2.20

9.36

1.8

1.29

1.35

umol/l

0.71

205

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

193

2.49

9.14

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

401

2428

1.40

9.13

3.0

2.9

47.68

53.46

mg/l

0.15

295

1734

(3026051) Granulocytes/Leukocytes in Pleural fluid

122

561

1.84

8.98

1.4

22.11

22.47

0.05

101

472

(3008536) Aspergillus sp Ab [Presence] in Serum

122

562

1.83

8.93

1.7

2.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

979

6718

1.23

8.88

2.0

1.8

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

279

1588

1.48

8.88

1.3

4.16

4.73

umol/l

1.71

238

1410

(3052592) Norovirus Ag [Presence] in Stool

108

481

1.90

8.79

1.2

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

197

2.44

8.78

2.0

2.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

208

2.39

8.71

1.8

52.48

45.94

umol/l

0.58

208

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

279

2.18

8.56

1.0

8.94

2.08

u/ml

0.34

131

(3020650) Glucose [Presence] in Urine

196

1043

1.59

8.50

1.7

1.5

0.02

0.05

estimate

1.25

196

1043

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

222

2.32

8.41

1.7

1.6

2.95

2.27

mg/l

0.44

154

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

222

2.32

8.41

1.7

1.6

0.39

1.31

mg/l

2.52

144

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

222

2.32

8.41

1.7

1.6

2.07

2.31

mg/l

0.13

167

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

222

2.32

8.41

1.7

1.6

1.11

0.78

mg/l

0.26

158

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

222

2.32

8.41

1.7

1.6

1.91

1.68

mg/l

0.12

150

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

222

2.32

8.41

1.7

1.6

2.47

2.42

mg/l

0.02

161

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

222

2.32

8.41

1.7

1.6

2.75

3.79

mg/l

0.79

143

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

354

2.03

8.40

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

260

2.21

8.36

2.6

2.7

25.65

24.45

mg/l

0.25

241

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

271

2.18

8.35

1.0

1.1

0.17

2.98

u/ml

1.94

213

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

182

956

1.61

8.34

1.0

0.46

0.75

u/ml

0.76

177

936

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

223

2.31

8.33

1.7

1.6

1.33

1.97

mg/l

0.59

142

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

223

2.31

8.33

1.7

1.6

1.85

1.79

mg/l

0.03

163

(3044009) aPTT.lupus sensitive (LA screen)

239

2.26

8.32

1.2

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

177

2.48

8.29

1.6

1.4

17.81

15.88

pmol/l

0.35

161

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

213

2.34

8.29

1.4

1.2

0.60

0.54

iu/ml

0.12

108

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

229

2.28

8.27

1.7

1.6

1.79

1.61

mg/l

0.12

158

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

138

2.69

8.25

5.2

4.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

306

2.10

8.22

2.2

2.6

0.62

0.56

u/field

0.18

306

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

194

1041

1.57

8.15

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

120

2.81

8.14

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

274

2.16

8.14

1.0

0.09

0.81

u/ml

1.03

129

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

259

2.18

8.04

1.0

0.22

0.59

u/ml

0.78

124

(3026470) Cobalt [Mass/volume] in Blood

280

1629

1.45

8.03

2.3

2.2

3.10

3.75

ug/l

1.09

253

1515

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

137

677

1.71

7.97

1.1

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

240

1357

1.49

7.95

2.2

26.33

35.59

umol/l

0.43

114

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

103

468

1.86

7.93

5.8

6.2

2460.20

2100.21

iu/ml

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

175

923

1.60

7.92

2.8

3.1

4.92

4.94

kpa

0.13

175

923

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

175

923

1.60

7.92

2.8

3.1

10.42

10.38

kpa

0.05

175

923

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

138

685

1.70

7.90

1.2

9.89

12.17

pmol/l

0.60

250

(3023410) Appearance of Cerebral spinal fluid

488

3123

1.32

7.86

1.4

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

209

1151

1.53

7.85

1.2

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

343

2079

1.39

7.84

1.3

1.4

12.78

12.39

umol/l

0.48

326

1967

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

182

2.41

7.84

1.0

1.1

0.01

0.44

u/ml

1.76

182

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

188

2.38

7.76

2.5

4.2

1.93

2.19

mg/l

0.56

158

(3025577) Chromium [Mass/volume] in Blood

270

1571

1.45

7.76

2.3

2.2

2.16

2.32

ug/l

0.40

219

1323

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

477

3051

1.32

7.72

1.3

—

(3003694) ABO and Rh group [Type] in Blood

10786

86530

1.07

7.66

1.5

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

417

2625

1.34

7.55

1.3

8.90

8.63

mmol/l

0.62

404

2486

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

150

2.53

7.52

1.3

1.1

63.52

93.19

u/l

0.33

131

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

256

1484

1.46

7.51

1.5

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

239

1367

1.48

7.51

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

239

1368

1.48

7.49

1.5

1.6

—

(3051651) Icteric interference index of Serum or Plasma

272

1597

1.44

7.47

3.6

3.8

0.81

0.88

index

0.36

260

1562

(3036312) Salmon IgE Ab [Units/volume] in Serum

171

2.42

7.45

1.0

1.1

0.59

1.55

u/ml

0.74

120

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

221

1248

1.50

7.41

1.6

1.8

1.49

2.77

u/ml

1.39

353

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

700

4734

1.25

7.34

1.1

26.84

3151.12

iu/ml

0.73

145

948

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

510

5527

0.78

7.34

1.6

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

303

1821

1.41

7.32

1.2

1.3

0.55

0.66

ratio

1.99

190

1037

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

354

2195

1.36

7.10

1.4

1.3

161.34

187.40

pmol/l

1.10

354

2195

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

362

4087

0.74

7.07

1.5

54.93

59.73

ug/l

1.58

362

4087

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

308

1869

1.39

7.05

1.2

1.1

0.96

3.80

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

108

519

1.76

6.99

2.2

2.4

7.29

7.52

mmol/l

0.25

310

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

453

2922

1.31

6.96

1.4

1.3

1.51

1.44

nmol/l

0.62

418

2638

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

336

1.93

6.77

2.0

2.3

1.06

1.39

mmol/l

0.74

237

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

164

887

1.56

6.75

1.1

5.50

4.51

u/ml

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

3.02

6.73

1.3

1.8

217.29

240.29

nmol/l

0.08

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

210

1199

1.48

6.72

1.1

100.36

97.50

0.58

173

947

(3047189) Immunofixation for 24 hour Urine

219

1261

1.47

6.71

1.7

1.9

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

405

1.83

6.59

4.8

5.6

53.50

41.44

ug/min

0.81

313

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

358

1.89

6.54

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

248

2.07

6.53

1.9

1.5

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

424

2737

1.31

6.51

1.6

1.5

33.32

31.17

0.53

246

1695

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

371

2352

1.33

6.48

1.7

1.8

3.85

3.69

mg/l

0.29

356

2254

(3041672) Baker's yeast Ab [Presence] in Serum

136

2.48

6.47

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

167

2.32

6.47

1.0

0.14

1.63

u/ml

1.17

127

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

141

745

1.60

6.43

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

277

1681

1.39

6.39

2.6

2.8

38.94

38.80

0.04

165

896

(3009466) Valproate [Moles/volume] in Serum or Plasma

643

4380

1.24

6.39

4.9

5.5

347.79

365.44

umol/l

2.49

570

3843

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

258

1548

1.41

6.36

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

283

1726

1.38

6.34

1.0

0.40

1.08

u/ml

0.91

388

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

351

1.87

6.29

1.3

—

(40765096) Chromosome analysis panel by Banding

156

850

1.55

6.25

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.67

6.24

1.4

1.3

1.51

2.22

mmol/24h

1.89

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

462

1.75

6.24

1.3

59.02

119.73

ng/l

1.79

290

(40763791) Oxygen content in Venous blood by calculation

3.15

6.23

4.8

8.4

12.12

12.45

ml/dl

0.18

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

165

913

1.53

6.17

1.3

1.5

72.74

72.71

0.01

159

877

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

237

2.06

6.15

1.2

1.3

17.47

16.95

nmol/l

0.06

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

111

560

1.67

6.10

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

264

1603

1.39

6.10

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

142

762

1.57

6.10

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

111

561

1.67

6.06

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

111

561

1.67

6.06

1.2

1.1

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

3.73

6.06

1.0

—

1.24

—

(4034850) Laboratory test

1242

9041

1.16

6.02

11.2

9.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

190

2.18

5.94

5.8

6.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

102

2.65

5.91

1.4

1.3

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

161

896

1.52

5.89

1.4

1.5

1075.04

659.78

mu/l

0.31

155

860

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

132

703

1.58

5.87

1.5

1.3

41.89

40.09

0.20

473

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

29141

249537

0.95

5.85

27.3

18.8

331.88

332.49

g/l

25.94

29032

248160

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

265

1.97

5.84

1.2

0.12

0.41

u/ml

1.10

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

221

2.06

5.73

1.0

0.03

1.98

u/ml

2.65

159

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.40

5.71

1.0

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

194

2.13

5.66

1.0

0.19

0.26

u/ml

0.31

111

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

470

1.71

5.65

2.5

2.8

47.19

45.09

mg/l

0.06

114

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

178

2.18

5.63

1.1

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

409

1.75

5.57

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

569

3887

1.24

5.57

1.5

1.4

33.56

33.33

g/l

0.17

517

3549

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

185

2.14

5.52

1.3

1.2

12.33

22.73

0.78

(3023436) Glucagon [Mass/volume] in Serum or Plasma

142

2.32

5.50

1.9

1.8

191.67

198.61

ng/l

0.24

130

(3020123) Porphyrins [Interpretation] in Serum or Plasma

153

2.26

5.47

1.1

—

(40768806) Pleura Pathology biopsy report

437

2903

1.27

5.47

1.6

1.5

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

164

2.21

5.46

1.1

14.98

37.28

u/ml

2.24

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

164

2.21

5.46

1.1

30.91

21.15

u/ml

0.66

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

127

2.39

5.45

1.3

1.6

0.36

0.06

u/l

0.76

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

308

1.86

5.44

2.0

1.7

1.33

1.76

mg/l

2.33

260

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

3.03

5.42

1.6

1.8

226.83

284.28

nmol/l

0.20

(3006567) Chloride [Moles/time] in 24 hour Urine

3.31

5.40

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

238

1.98

5.39

2.8

2.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

399

2632

1.28

5.30

1.4

1.3

615.32

480.21

u/l

0.38

374

2511

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

246

1.95

5.27

1.5

1.3

10.46

13.85

pmol/l

0.49

206

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

130

712

1.54

5.18

1.2

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2002

15201

1.12

5.14

2.1

2.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

484

1.66

5.11

1.9

2.5

1.19

mmol/l

0.09

463

(3030313) Adrenal Ab [Titer] in Serum

243

1.94

5.11

1.3

1.1

22.20

39.59

titre

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

334

1.79

5.06

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

555

3825

1.23

5.05

1.3

6.97

7.24

mmol/l

1.50

498

3349

(43055442) Apixaban [Mass/volume] in Serum or Plasma

422

1.70

5.04

1.7

1.6

103.55

112.79

ug/l

0.37

346

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

378

1.74

5.04

1.1

—

(44806420) Estimation of glomerular filtration rate

521

3570

1.23

5.01

2.7

2.4

—

(3016750) Collection duration of Urine

245

1522

1.36

5.01

2.3

2.2

505.39

499.34

min

0.47

193

1092

(3028308) Erythrocytes [#/volume] in Pleural fluid

452

3050

1.25

5.00

1.5

1.4

72901.77

50962.11

e6/l

0.54

268

1745

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

325

1.79

4.91

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

5.13

4.89

1.1

1247.14

2785.22

titre

1.75

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

224

1.96

4.86

1.1

100.92

96.71

titre

0.15

224

(3023487) Leukocytes [#/volume] in Peritoneal fluid

155

896

1.46

4.80

2.1

1.7

665.69

4832.09

e6/l

2.13

109

572

(3004775) Volume in Urine collected for unspecified duration

318

2067

1.30

4.78

2.4

2.3

712.56

660.90

1.48

225

1376

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

129

719

1.51

4.78

9.1

8.1

5.87

6.00

kpa

1.07

111

649

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

186

1114

1.41

4.76

1.2

—

(4198724) Urine methamphetamine measurement

199

1206

1.39

4.76

1.9

2.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

174

1030

1.43

4.76

1.2

0.81

0.32

g/l

0.52

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

279

1783

1.32

4.75

6.3

7.3

18.81

89.65

ug/l

2.25

172

1167

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

230

1428

1.36

4.75

1.2

9.92

10.22

mm/h

0.15

230

1428

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

197

2.01

4.75

1.0

1.1

6.68

10.30

u/l

1.26

197

(3034988) Calcium [Moles/volume] in Capillary blood

475

1.63

4.73

2.0

2.4

1.18

1.19

mmol/l

0.36

452

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

134

757

1.49

4.67

1.2

1.3

114.39

298.84

ug/l

1.32

409

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

422

0.38

4.61

1.4

1.2

65.58

68.48

ug/l

0.16

422

(3017569) Oxygen content in Arterial blood

253

1605

1.33

4.55

2.4

2.1

15.75

16.04

0.68

253

1605

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

299

1945

1.30

4.50

1.4

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

162

2.08

4.44

1.1

1.4

4.32

5.60

u/ml

0.16

141

(3026692) Albumin [Mass/volume] in Peritoneal fluid

112

616

1.53

4.44

1.5

1.2

12.65

14.50

g/l

1.42

481

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

361

1.71

4.44

1.9

1.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

498

3445

1.22

4.43

1.5

1.4

4649.57

3004.30

e6/l

0.39

364

2434

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

374

1.69

4.43

1.2

1.4

55.54

51.10

0.30

177

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

681

4853

1.19

4.41

1.5

1.4

0.34

0.37

nmol/l

0.49

521

3651

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

200

1231

1.37

4.40

2.6

2.4

55.02

51.78

umol/l

0.70

171

1071

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

309

2027

1.29

4.38

1.0

343.50

337.79

ng/l

0.04

221

1474

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

460

1.61

4.35

1.7

1.5

—

(3034891) Synovial lining cells/cells in Synovial fluid

231

1461

1.33

4.27

1.5

4.73

4.13

0.20

315

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

206

1.92

4.23

2.3

3.1

5.86

387.36

pmol/l

0.59

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

313

2068

1.28

4.21

1.3

13.43

14.65

u/l

0.30

289

1911

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

113

631

1.51

4.21

1.1

1.2

68.58

76.71

0.73

177

(3035320) C reactive protein [Mass/volume] in Body fluid

344

2302

1.26

4.17

2.8

2.6

28.79

28.86

mg/l

0.01

258

1636

(3005011) Chlamydia sp Ab [Titer] in Serum

364

1.67

4.07

1.7

1.6

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

488

1.57

4.07

1.4

1.3

471.40

321.75

titre

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

308

2041

1.27

4.06

1.0

46.03

40.80

ng/l

0.35

216

1458

(3032641) Amino acids panel - Urine

4.38

4.05

1.1

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

121

692

1.48

4.03

1.1

1.2

232.00

308.72

titre

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

117

665

1.48

4.02

1.2

1.3

106.88

107.63

0.09

106

638

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

372

1.66

4.01

1.1

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

457

1.59

4.00

1.5

0.19

0.25

nmol/l

0.82

320

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

2.64

3.96

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

176

1.96

3.94

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

156

941

1.40

3.92

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

332

3490

0.80

3.92

1.5

1.4

3.74

3.67

ug/l

0.03

279

2994

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

212

1.87

3.91

1.1

16.00

18.81

iu/ml

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2363

18360

1.09

3.88

2.2

2.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

402

2763

1.23

3.87

1.4

1.3

6.15

6.30

mmol/l

0.40

375

2580

(3035947) Staphylolysin Ab [Units/volume] in Serum

223

1426

1.32

3.87

1.1

3.35

4.31

iu/ml

0.81

101

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

229

1470

1.31

3.87

1.3

5.85

5.72

mmol/l

0.59

218

1380

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

121

2.16

3.82

1.1

1.2

379.08

473.09

u/l

0.23

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

116

2.18

3.78

1.0

1.1

0.01

1.52

u/ml

1.59

116

(3049233) Organic acids panel - Urine

3.28

3.78

1.3

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

305

2039

1.26

3.77

1.0

803.34

752.74

ng/l

0.98

211

1429

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

2.72

3.77

1.1

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

179

1.93

3.77

1.1

—

(3042517) Benzodiazepines panel - Urine

302

1.70

3.76

2.2

2.6

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

266

1751

1.28

3.74

12.4

13.6

0.59

0.63

mmol/l

2.17

240

1618

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.31

3.74

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.08

3.69

1.0

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

461

1.56

3.66

2.6

2.8

2471.74

1197.00

u/l

0.37

412

(3013336) Amino acids [Identifier] in Serum or Plasma

2.67

3.66

3.2

2.0

—

(4133840) Spirometry

135

805

1.41

3.65

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

107

611

1.48

3.64

1.1

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

230

1.80

3.63

1.2

95.66

90.02

ug/l

0.12

141

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

130

773

1.42

3.58

2.0

1.6

14167.72

14049.05

e6/l

0.01

380

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.26

3.58

3.2

4.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

424

1.57

3.57

1.7

1.6

—

(3013727) Leukocytes other/Leukocytes in Blood

141

851

1.40

3.57

4.0

3.7

49.40

52.88

1.11

135

822

(3024263) Appearance of Synovial fluid

223

1445

1.30

3.56

2.3

1.6

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

132

2.04

3.46

1.4

1.6

470.42

512.51

nmol/l

0.13

132

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

138

2.02

3.44

15.8

11.6

102.33

104.76

g/l

0.58

138

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

153

943

1.37

3.44

1.2

875.00

1022.00

titre

0.63

200

(43055514) Macroprolactin [Presence] in Serum or Plasma

118

696

1.43

3.42

1.2

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

111

648

1.45

3.40

9.5

8.0

6.07

5.44

kpa

1.12

111

648

(3001556) Androgen free Index in Serum or Plasma

229

1.77

3.39

1.3

1.2

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

2.81

3.39

1.1

1.0

0.01

0.13

u/ml

0.83

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.48

3.37

1.2

1.4

154.67

149.14

nmol/l

0.06

(3000876) Codfish IgE Ab [Units/volume] in Serum

7.38

3.35

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

109

637

1.44

3.33

1.1

1.2

90.88

88.03

0.17

190

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

140

1.99

3.32

1.2

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

457

3234

1.19

3.32

1.6

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

294

1.66

3.32

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

256

1.71

3.31

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

282

1.67

3.29

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

148

916

1.36

3.26

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

558

0.56

3.19

3.1

3.3

43.38

45.51

0.26

558

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

557

0.56

3.17

6.3

6.6

9.51

8.51

0.55

557

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

222

1.75

3.15

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

384

1.56

3.15

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

780

5782

1.14

3.14

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

325

1.61

3.14

1.1

1.2

—

(3044007) Cell count panel - Peritoneal fluid

125

759

1.39

3.11

2.1

1.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

399

1.54

3.10

1.0

—

(3013466) aPTT in Blood by Coagulation assay

156

1.89

3.09

1.1

34.70

37.66

3.04

135

(3003740) Influenza virus B Ag [Presence] in Specimen

779

5782

1.14

3.08

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

106

627

1.43

3.07

2.1

1.3

0.31

0.27

mmol/l

0.10

112

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

321

1.60

3.05

1.3

1.2

5.94

5.97

mmol/l

0.06

321

(3007700) Barley IgE Ab [Units/volume] in Serum

140

1.93

2.99

1.0

0.10

0.46

u/ml

0.86

(3002619) Bacteria identified in Specimen by Culture

126

774

1.37

2.95

1.2

1.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

345

1.56

2.91

2.9

2.7

58.64

61.49

pmol/l

0.11

297

(3042628) Porphyrins [Moles/volume] in Urine

7.23

2.90

1.2

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.75

2.87

1.0

1.1

0.07

0.77

u/ml

1.10

(3044416) Complement C4 [Mass/volume] in Pleural fluid

113

2.01

2.86

1.4

1.2

0.06

0.08

g/l

1.44

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

583

1.42

2.79

9.9

6.5

66.99

70.91

0.68

459

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.50

2.77

1.9

2.1

28.66

27.81

0.06

(3001218) Citrate [Mass/time] in 24 hour Urine

2.58

2.76

1.5

1.4

321.07

409.41

mg/24h

0.45

(40768795) Lymph node Pathology biopsy report

428

3068

1.18

2.76

1.3

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

219

1.69

2.75

1.0

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

194

1.74

2.74

1.4

1.1

43.95

48.36

mg/l

0.30

(3033086) Enterovirus Ab [Titer] in Serum

2.19

2.73

1.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

139

1.88

2.72

1.0

6.45

18.96

u/ml

1.82

111

(3020393) Adenovirus Ag [Presence] in Stool

311

1.57

2.72

1.4

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

210

1404

1.26

2.72

1.1

—

(4212803) Bone marrow aspirate examination

201

1.72

2.71

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.07

2.69

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.07

2.69

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.07

2.69

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.07

2.69

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.07

2.69

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.07

2.69

2.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

122

1.94

2.68

1.3

1.1

2132.24

4285.68

ng/l

1.30

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

2.30

2.63

9.5

9.0

42.40

44.40

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

143

1566

0.77

2.53

1.6

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

121

1355

0.75

2.52

1.4

1.5

29.37

34.03

nmol/l

0.95

106

1229

(3023383) Lactate [Moles/volume] in Pleural fluid

130

826

1.33

2.51

1.4

1.3

3.12

3.54

mmol/l

0.99

112

769

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

148

958

1.30

2.50

1.1

1.2

18.80

21.95

0.16

157

(3042301) Urate [Moles/volume] in Synovial fluid

2.43

2.48

1.0

388.44

339.65

umol/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

103

633

1.37

2.47

1.1

24.64

30.27

iu/ml

0.52

103

633

(3002331) Protein [Mass/volume] in Peritoneal fluid

562

1.40

2.46

1.3

24.85

71.22

g/l

0.82

448

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

221

1508

1.24

2.44

5.3

6.4

44.61

3403.26

u/ml

0.80

272

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

202

1.67

2.41

2.0

1.8

58.55

60.83

0.11

131

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.20

2.40

1.4

1.2

30.69

34.67

mg/24h

0.32

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

189

1270

1.26

2.40

2.1

82.45

106.38

ug/min

0.36

270

(3013945) Hepatitis B virus e Ab [Presence] in Serum

177

1.72

2.39

1.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.02

2.38

2.0

4.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

289

1.55

2.36

2.2

2.6

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.29

2.33

1.0

1.75

0.49

u/ml

0.35

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

123

1.85

2.30

1.1

1.0

0.03

0.20

u/ml

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

142

1.78

2.28

1.1

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

219

1.62

2.26

1.4

1.3

1.24

1.49

ml/s/173m2

0.23

141

(3027974) Hepatitis B virus e Ag [Presence] in Serum

187

1.67

2.25

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

187

1.67

2.25

1.2

1.1

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.03

2.22

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

157

1046

1.27

2.17

2.4

3.1

28.59

28.64

umol/l

0.02

107

802

(3005532) Lymphocytes/Leukocytes in Pleural fluid

138

905

1.29

2.17

1.5

1.4

62.32

62.61

0.03

113

760

(3034426) Prothrombin time (PT)

139

915

1.28

2.13

1.2

27.69

28.18

0.46

139

915

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.95

2.09

1.0

1.1

155.70

232.36

pmol/l

—

(3012898) Urea [Moles/volume] in Urine

305

1.49

2.09

1.3

1.5

163.47

175.31

mmol/l

0.26

265

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.91

2.09

2.0

4.1

30983.33

465338.48

u/ml

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

278

1.52

2.08

1.1

231.88

346.40

u/ml

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

179

1.65

2.06

1.6

1.3

286.91

322.35

umol/24h

0.72

179

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

148

1.71

2.01

4.9

3.6

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

142

1.72

2.00

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

111

1.82

1.99

1.0

0.12

0.66

u/ml

1.47

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

260

1851

1.19

1.94

19.9

20.4

1358.36

3156.19

nmol/l

1.06

247

1781

(3017461) Flecainide [Moles/volume] in Serum or Plasma

157

1.66

1.91

1.7

0.65

0.75

umol/l

0.55

126

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

113

1.79

1.89

1.1

1.0

0.02

0.13

u/ml

—

(3016031) Almond IgE Ab [Units/volume] in Serum

204

1.57

1.87

1.0

0.28

1.00

u/ml

1.48

112

(3001019) Free T4 and TSH panel - Serum or Plasma

1972

15688

1.06

1.87

1.7

—

(40758292) HTLV I+II Ab panel - Serum

578

1.33

1.85

1.3

1.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.24

1.84

3.8

2.4

1.44

3.36

mu/l

0.97

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.95

1.82

1.2

1.1

—

mmol/l

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.95

1.82

1.3

1.7

146.20

116.08

ug/l

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.30

1.80

1.1

1.4

1.67

2.14

g/l

0.73

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

372

1.41

1.80

1.4

1.3

97.47

70.32

u/l

0.17

267

(3041184) Isoniazid [Presence] in Urine

2.62

1.80

2.9

2.4

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

3.11

1.79

1.0

1.1

379.43

267.53

nmol/l

—

(3051101) Glucose [Moles/volume] in Cord blood

512

0.67

1.75

4.6

5.6

8.30

8.43

mmol/l

0.12

512

(3044242) Glucose [Moles/volume] in Arterial blood

223

1586

1.19

1.72

2.1

1.8

8.13

8.12

mmol/l

0.02

223

1586

(3007456) Orange IgE Ab [Units/volume] in Serum

1.98

1.71

1.1

1.0

0.03

0.22

u/ml

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

2.95

1.70

1.7

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

111

1.75

1.70

1.0

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

176

1.58

1.69

1.1

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

294

2142

1.16

1.69

2.1

1.8

—

(44786800) Granulocytes/Leukocytes in Body fluid

293

1.44

1.67

1.5

1.3

29.18

23.15

0.56

228

(3036180) Methadone [Presence] in Urine

2.20

1.65

3.1

2.2

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.59

1.63

1.0

1.2

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

119

1.70

1.63

1.0

0.08

0.46

u/ml

1.47

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

192

1.54

1.61

1.1

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

107

1.73

1.60

1.1

274.66

278.38

nmol/l

0.03

107

(3045177) Copper [Moles/volume] in Urine

2.15

1.57

1.0

1.1

0.21

0.43

umol/l

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

154

1.59

1.54

1.1

1.40

1.13

u/field

0.59

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

128

1.65

1.53

12.2

8.5

—

(3026480) Teichoate Ab [Titer] in Serum

250

1.45

1.52

1.1

—

2.25

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1351

10703

1.07

1.52

1.5

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

195

1.51

1.52

1.3

1.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

375

0.65

1.51

1.0

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.92

1.48

1.0

1.32

3.65

u/ml

0.83

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

242

1759

1.16

1.48

14.7

15.2

788.06

2124.75

nmol/l

0.83

232

1705

(3042010) Triglyceride [Moles/volume] in Pleural fluid

445

1.33

1.48

1.2

1.3

1.49

1.33

mmol/l

0.09

292

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

232

1.45

1.3

1.4

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.72

1.44

1.0

0.15

0.48

u/ml

1.05

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

131

1.61

1.41

14.1

10.4

141.25

369.64

e6/l

0.92

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.22

1.41

1.0

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

169

0.50

1.40

1.1

0.79

1.28

mom

—

169

(3035880) pH of Pleural fluid

202

1458

1.17

1.38

1.3

7.40

0.13

144

1040

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

301

2237

1.14

1.37

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

3.01

1.36

1.2

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.01

1.36

1.2

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

113

1.64

1.35

1.3

1.07

1.11

u/field

0.09

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

2.16

1.34

1.0

0.14

3.70

u/ml

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

286

1.39

1.33

3.4

3.0

1.18

1.23

mg/l

0.13

199

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

233

1706

1.15

1.33

1.2

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

536

1.27

1.31

1.3

1.2

1.55

1.67

mmol/l

0.40

334

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.92

1.31

4.9

5.6

0.26

0.24

mmol/l

0.10

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.92

1.31

1.2

1.1

251.38

281.77

u/ml

0.19

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.81

1.27

1.0

1.2

18.78

38.40

nmol/24h

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

156

1.51

1.25

1.9

1.6

22.50

17.37

0.24

(3045788) Cell count panel - Pleural fluid

370

2806

1.11

1.23

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

100

686

1.23

1.21

2.5

3.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.71

1.21

2.4

2.1

289.74

237.76

ug/l

0.40

(3007542) Rye IgE Ab [Units/volume] in Serum

158

1.49

1.19

1.0

0.19

0.35

u/ml

0.35

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.63

1.19

1.0

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

113

1140

0.84

1.13

2.7

2.6

157.55

150.64

nmol/l

0.20

1012

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

106

740

1.21

1.11

2.0

32.10

39.96

u/l

0.21

672

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

490

1.26

1.10

6.5

7.0

10.84

10.59

0.49

490

(3024316) Viscosity of Plasma

141

1.49

1.09

2.2

1.8

1.81

1.71

mpas

0.31

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

155

1.47

1.08

1.2

2501.19

910.18

u/l

0.34

141

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

129

1.50

1.03

1.1

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

102

1.57

1.03

1.2

1.1

0.91

0.95

u/field

0.09

(3019832) Treponema pallidum Ab [Presence] in Serum

3281

26844

1.03

1.02

1.8

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

193

1.40

1.01

1.0

1.1

1.98

7.06

u/ml

2.37

113

(40765089) Chromosome analysis panel - Blood by G-banded

822

0.82

1.00

1.0

—

(3008717) Parietal cell Ab [Titer] in Serum

2.22

0.99

1.0

1.1

358.40

768.53

titre

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

109

774

1.19

0.98

1.6

1.4

2.56

2.85

0.16

668

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

173

1.41

0.98

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

267

1.33

0.97

1.5

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.64

0.97

11.0

8.4

—

(3006598) pH of Arterial cord blood

158

0.59

0.96

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

160

1.42

0.95

1.6

2.3

2.33

8.80

nmol/l

1.24

147

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

396

3064

1.09

0.95

4.1

4.2

62.62

52.76

u/ml

0.23

386

3036

(3013247) Albumin in CSF/Albumin in Serum or Plasma

677

1.20

0.94

1.1

6.18

7.09

mg/g

0.85

645

(3017509) Phencyclidine [Presence] in Urine

313

1.29

0.94

1.9

1.5

—

(40768800) Prostate Pathology biopsy report

679

6096

0.94

0.92

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.71

0.90

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.11

0.90

1.0

0.05

0.21

u/ml

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.53

0.90

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

141

1.44

0.89

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.82

0.86

1.0

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.58

0.85

1.0

1.3

294.27

366.33

pmol/l

0.33

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

364

1.25

0.84

1.1

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

267

1.29

0.83

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

342

1.26

0.83

1.5

1.4

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.76

0.81

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

202

1.34

0.81

1.9

2.2

0.66

ug/l

0.01

202

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.57

0.79

1.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

262

1.29

0.79

1.2

18.43

17.40

g/l

0.34

244

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

384

1.23

0.77

1.7

1.4

13.22

12.12

0.11

200

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

29336

248395

0.98

0.77

26.1

18.0

13.73

13.57

81.19

29100

245087

(3022725) Serotonin [Moles/volume] in Serum

104

1.46

0.75

1.4

1.5

655.89

818.50

nmol/l

0.36

(3000919) Neutrophils/Leukocytes in Pleural fluid

711

1.16

0.74

1.4

22.01

21.69

0.04

654

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.65

0.74

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

199

1.31

0.72

5.0

5.8

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

113

1.42

0.69

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

168

1274

1.11

0.67

3.7

3.3

1.41

1.31

0.24

168

1274

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.83

0.67

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.76

0.64

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

189

1.29

0.63

2.3

2.6

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.48

0.63

1.0

1.1

5.60

13.12

mg/l

—

(3018291) Platelet Ab [Presence] in Serum

1.61

0.61

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.61

0.61

1.1

3442.00

3652.95

titre

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1196

9734

1.04

0.60

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

695

1.14

0.59

2.4

3.1

116.24

107.08

ng/l

0.22

355

(3016273) Islet cell 512 Ab [Units/volume] in Serum

186

0.72

0.58

1.2

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.58

0.0

2.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.74

0.58

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

1.74

0.58

1.0

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

162

1.30

0.57

1.1

1.0

—

(3022475) Manganese [Moles/volume] in Blood

177

1.29

0.57

1.1

1.3

0.16

umol/l

0.07

177

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

558

4944

0.95

0.57

3.5

3.8

31.47

38.07

u/ml

0.82

528

4784

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

407

1.18

0.57

6.5

9.3

0.33

0.35

umol/l

0.26

362

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.52

0.56

1.0

1.1

3.27

2.67

0.15

(3034614) HLA Ag [Interpretation]

1.49

0.56

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

767

6199

1.04

0.56

4.4

3.2

23.90

27.26

mg/l

2.04

533

4267

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.58

0.54

1.5

1.1

1.83

1.44

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

172

1.27

0.52

1.1

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.59

0.52

1.0

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.41

0.51

1.2

1.1

0.63

0.04

g/l

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

188

1.26

0.51

1.1

1.6

10.05

12.95

0.53

130

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

234

1.22

0.50

1.3

1.1

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

296

1.20

0.50

1.5

1.4

68.93

73.06

0.37

257

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

575

0.86

0.50

1.9

2.0

2.12

2.87

ug/l

0.65

364

(3007463) Buprenorphine [Presence] in Urine

114

1.33

0.49

5.7

6.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

218

1710

1.08

0.48

1.6

8.27

7.85

mmol/l

1.60

209

1646

(3046861) Legionella sp Ag [Presence] in Urine

192

1.23

0.44

1.1

—

(3013762) Body weight Measured

0.63

0.42

1.0

1.2

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

163

1.24

0.42

1.1

1.4

2.11

1.48

0.17

103

(3007919) Fasciola sp Ab [Titer] in Serum

1.43

0.41

1.0

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.35

0.40

1.2

1.1

0.17

0.06

g/l

—

(4038314) Semen analysis, post vasectomy

157

1.24

0.39

1.1

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.35

0.38

5.4

3.9

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.36

0.36

1.2

1.1

—

(3003577) Lead [Moles/volume] in Blood

253

1.17

0.35

1.1

1.5

0.16

0.28

umol/l

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

168

1.20

0.34

3.6

2.9

12.25

12.15

0.01

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

318

1.14

0.33

1.3

1.2

—

(3025130) Human papilloma virus identified in Specimen

584

4770

1.03

0.32

1.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

471

1.11

0.32

1.3

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

288

1.14

0.31

1.1

18.45

21.08

u/l

0.56

170

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

109

1.24

0.29

1.0

—

(40760410) HLA-B [Type] by High resolution

126

1.20

0.26

1.0

—

(46236302) HLA-C [Type] by High resolution typing

126

1.20

0.26

1.0

—

(40760409) HLA-A [Type] by High resolution

126

1.20

0.26

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

163

0.83

0.26

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

413

1.10

0.26

2.3

2.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

213

1879

0.96

0.26

1.8

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.67

0.26

1.0

160.20

163.71

g/l

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.25

0.25

1.0

1.1

—

(3001729) Color of Synovial fluid

215

1.14

0.23

1.9

1.7

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.32

0.23

2.0

2.3

—

(3010937) Rubella virus Ab [Presence] in Serum

187

0.86

0.23

1.1

—

(3035060) Mercury [Moles/volume] in Blood

1.24

0.22

1.4

2.0

14.18

14.05

nmol/l

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.21

0.0

1.6

—

0.06

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.4

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.21

0.0

1.1

—

2.30

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

443

1.08

0.21

1.0

1.1

12.83

9.09

u/ml

0.22

443

(3019298) Eosinophils/Leukocytes in Peritoneal fluid

1.18

0.19

2.2

1.1

0.00

0.66

—

(3022670) pH of Venous cord blood

1.11

0.17

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.22

0.17

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.14

0.16

1.0

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.14

0.16

3.4

6.7

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

119

0.85

0.16

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

360

1.08

0.16

4.2

3.1

41.28

42.10

umol/l

0.09

314

(4281824) Cell count and differential, peritoneal fluid

377

3249

0.98

0.15

1.2

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

206

1.10

0.15

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

135

0.87

0.14

1.4

1.2

—

(3014891) Appearance of Pleural fluid

353

0.93

0.13

1.7

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

306

1.07

0.13

1.1

—

(3013862) HLA-DP [Type]

128

1.12

0.12

1.0

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

218

1.08

0.11

1.1

1.5

44.57

38.64

0.32

140

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

281

0.93

0.11

1.5

1.2

20.79

20.94

mmol/l

0.04

227

(3020356) Listeria sp identified in Specimen by Organism specific culture

162

1.09

0.10

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

500

1.05

0.10

2.1

1.9

—

(40758358) Immune stain study

130

1.10

0.09

1.0

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

1.05

0.09

1.2

1.5

193.66

124.88

nmol/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

510

1.04

0.09

1.6

1.3

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

101

827

1.03

0.08

1.6

1.4

53.38

54.33

0.09

704

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.87

0.07

1.1

1.29

1.28

u/field

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

350

1.04

0.05

1.9

2.5

—

(40763590) HLA-DQ beta [Type]

126

1.07

0.04

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

373

0.97

0.04

2.0

6.51

7.45

mmol/l

0.85

131

(3000285) Sodium [Moles/volume] in Blood

553

1.02

0.04

1.3

1.2

138.15

138.31

mmol/l

0.11

468

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

125

0.94

0.02

2.2

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

161

1359

1.00

0.00

1.7

1.8

20.60

640.26

pmol/l

0.93

218

(1617658) Protocol used for examination of sentinel lymph nodes

268

2258

1.00

0.00

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

786

1.00

0.00

1.7

1.5

0.51

e9/l

0.00

786

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

345.00

—

(3028050) Streptolysin O Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

150.67

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(36305197) Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

1.80

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_REFLUX and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_REFLUX	1.086 [1.0, 1.18]	0.045
Birth year	0.994 [0.99, 1.0]	0.196

During the follow-up period (1.1.1998 — 31.12.2019), 15214 out of 108719 females with K11_REFLUX died.

Males

Parameter	HR [95% CI]	p-value
K11_REFLUX	1.289 [1.19, 1.4]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 18165 out of 94271 males with K11_REFLUX died.

Mortality risk

Mortality risk for people of age

years, who have K11_REFLUX.

N-year risk	Females	Males
1	0.114%	0.243%
5	0.634%	1.493%
10	1.6%	3.681%
15	2.999%	6.704%
20	5.296%	11.685%

Relationships between endpoints

↥

Index endpoint: K11_REFLUX – Gastro-oesophageal reflux disease

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Gastro-oesophageal reflux disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints